Finex logo
Finex Intelligence

Market Signal Briefing

Wire-ready dashboard awaiting your first source connection.

Last news saved at Mar 30, 13:54 1mo ago Cron last ran Mar 30, 13:54 1mo ago Awaiting first source
Switch language
91,488 Stories ingested Auto-fetched market intel nonstop.
0 Distinct tickers Add sources to start tracking symbols
Trending sources Waiting for fresh intel
Hot tickers Surfacing from current coverage
Details Saved Published Title Source Tickers
2026-02-24 14:11 2mo ago
2026-02-24 09:05 2mo ago
MicroVision Business Update and Fireside Chat on February 25, 2026 stocknewsapi
MVIS
REDMOND, WA / ACCESS Newswire / February 24, 2026 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced a video-enabled business update and fireside chat on February 25, 2026 at 10:00 AM ET with Glen DeVos, MicroVision's Chief Executive Officer. Having completed two strategic acquisitions in the first two months of 2026, the February 25 event offers the Company's shareholders, partners, and industry stakeholders an in-depth and candid view of MicroVision's strategic plan as it redefines the future of lidar.
2026-02-24 14:11 2mo ago
2026-02-24 09:05 2mo ago
Steppe Gold Announces Finance Leadership Transition stocknewsapi
STPGF
Ulaanbaatar, Mongolia--(Newsfile Corp. - February 24, 2026) -  Steppe Gold Ltd. (TSX: STGO) (OTCQX: STPGF) (FSE: 2J9) ("Steppe Gold" or the "Company") announces that Mr. Jeremy South has resigned from his role as Senior Vice President and Chief Financial Officer ("CFO") of the Company, effective March 10, 2026. The Board of Directors continues its review of the resignation and related matters.

Initially joining the Company as a member of the board of directors (the "Board") and serving as CFO since 2018, Mr. South has played a key role in guiding Steppe Gold from an early-stage development company, through the commencement of production during the global pandemic, into a multi-asset gold producer with a strong asset base in Mongolia and a clear long-term growth profile. He has been instrumental in shaping the Company's strategic and financial direction, building an institutional shareholder base and advancing corporate governance practices.

The Board has appointed Ms. Ariuntsetseg Batsaikhan as Interim CFO of the Company. She has served as the Company's Financial Controller since 2018, with over 15 years of finance experience in the mining sector. Ms. Batsaikhan holds a BSc (Hons) in Applied Accounting, Oxford Brookes University and an ACCA Advanced Diploma in Accounting and Business.

The Company is also currently undertaking a review of prior financial periods, and total assets remain subject to adjustment upon completion of the ongoing audit.

Steppe Gold remains focused on safe and efficient production, as well as disciplined capital allocation, to support long-term shareholder value.

Cautionary Statement on Forward-Looking Information

This news release contains certain statements or disclosures relating to the Company that are based on the expectations of its management as well as assumptions made by and information currently available to the Company which may constitute forward-looking statements or information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results, or developments that the Company anticipates or expects may, or will, occur in the future (in whole or in part) should be considered forward-looking statements. In some cases, forward-looking statements can be identified by the use of the words "commenced", "focused", "continued", "will", "commitment" and similar expressions. In particular, but without limiting the foregoing, this news release contains forward-looking statements pertaining to the following: the appointment of new executive leadership, commitment to governance standards, the timing and outcome of the Board's search process and the Company's future strategy and development plans. Such statements reflect the Company's current expectations and speak only as of the date of this news release. Except as required by applicable securities laws, the Company undertakes no obligation to update forward-looking statements.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/285077

Source: Steppe Gold Ltd.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-24 14:11 2mo ago
2026-02-24 09:06 2mo ago
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet? stocknewsapi
CRMD TBPH
Key Takeaways Theravance Biopharma is favored over CorMedix for its balanced risk-reward profile in 2026.TBPH benefits from Yupelri profit-sharing and a $225M Trelegy royalty sale, boosting cash runway.CorMedix expects to face slower 2026 DefenCath growth and pricing pressure amid rising competitive risks. CorMedix (CRMD - Free Report) and Theravance Biopharma (TBPH - Free Report) occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, having a market cap of less than $1 billion, are either in the early stages of commercialization or working to expand the reach of key therapies, which means their stock prices can move sharply on clinical updates, regulatory decisions and early sales trends. For investors, that creates a classic biotech setup — higher risk, but also the potential for meaningful upside if execution goes well.

CorMedix’s lead product, DefenCath (Taurolidine + Heparin), received FDA approval in late 2023 as the first and only antimicrobial catheter lock solution available in the United States. It is indicated for reducing catheter-related bloodstream infections in adult patients with kidney failure undergoing chronic hemodialysis through a central venous catheter.

Although Theravance’s commercial portfolio lacks a marketed product, the company has collaborated with Viatris (VTRS - Free Report) to develop and commercialize Yupelri, as a once-daily, nebulized treatment of chronic obstructive pulmonary disease (COPD).

While both companies face the usual risks and rewards of small-cap biotech investing, they are pursuing very different growth strategies. CorMedix is focused on driving near-term revenue through the commercial rollout of DefenCath, while Theravance is leveraging its stronger balance sheet to advance late-stage clinical programs and expand its pipeline. This contrast — immediate sales execution versus longer-term clinical upside — gives investors two distinct ways to play for the next potential growth story in the sector. Let’s dive into their fundamentals, growth outlook and potential challenges to make a well-informed comparison.

The Case for CRMD StockDefenCath is the first approved product in CorMedix’s marketed portfolio, giving the company a regular income stream. The product was launched in 2024 in both hospital inpatient and outpatient hemodialysis settings and has witnessed strong market adoption since.

Last month, CorMedix reported preliminary fourth-quarter and full-year 2025 results, with net revenues of approximately $127 million and $310 million, respectively. Preliminary net revenues for the fourth quarter and full-year 2025 reflect the growing momentum with DefenCath and early Melinta portfolio contributions. DefenCath holds a unique market position as the only FDA-approved therapy for a niche condition, supported by patent protection through 2033. CRMD is also planning future potential label expansion of DefenCath into total parenteral nutrition to increase its customer base

In August 2025, CorMedix took a significant step toward diversifying its revenues and reducing dependence on DefenCath with the $300 million acquisition of Melinta Therapeutics. The acquisition added seven approved therapies to CRMD’s portfolio, strengthening its presence in hospital acute care and infectious disease markets. The Melinta acquisition underscores CorMedix’s long-term strategy to accelerate growth by expanding its hospital-focused offerings while building a more durable, diversified commercial platform.

CorMedix’s latest future financial outlook has tempered investor expectations around DefenCath’s growth trajectory. Management introduced full-year 2026 revenue guidance of $300-$320 million, but DefenCath sales are expected to be front-loaded in early 2026, with only modest utilization gains offsetting ongoing pricing pressure. More importantly, the company projected 2027 DefenCath revenues of $100-$140 million based on higher net selling prices compared to 2026. Both guidance assumes flat usage among existing customers and excludes any benefit from new accounts, Medicare Advantage contracting, or reimbursement changes — signaling a more conservative, slower-growth outlook than many investors had anticipated and contributing to recent bearish sentiment. Amid such concerns, CorMedix’s heavy reliance on DefenCath for revenues remains a challenge.

The Case for TBPH StockThe Viatris collaboration is the primary top-line contributor for Theravance. Viatris and TBPH are sharing U.S. profits and losses received in connection with the commercialization of Yupelri. While Viatris gets 65% of the profits, Theravance receives the remaining 35%. Theravance is entitled to low double-digit royalties on ex-U.S. net sales. Viatris recognizes product sales from Yupelri. VTRS also owns a stake in Theravance.

Yupelri is a once-daily nebulized long-acting muscarinic antagonist (LAMA) approved for COPD patients. LAMAs are recognized by international COPD treatment guidelines as a cornerstone of maintenance therapy for COPD, irrespective of the severity of the disease. Yupelri provides COPD patients with access to a nebulized LAMA therapy, offering a consistent 24-hour lung function improvement with the convenience of once-daily dosing delivered through any standard jet nebulizer.

The product has been witnessing strong sales, generating higher profit-sharing revenues for Theravance. Revenues from the Viatris collaboration rose 18.5% year over year in the first nine months of 2025.

Theravance is developing its lead pipeline candidate, ampreloxetine (TD-9855), a norepinephrine reuptake inhibitor for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with multiple system atrophy (MSA).

The company initiated the phase III CYPRESS study evaluating ampreloxetine for nOH MSA in 2024. In August 2025, the company completed patient enrollment in the CYPRESS study. Top-line data from the same is expected in the first quarter of 2026. Theravance plans a regulatory filing, under the FDA’s priority review pathway, for ampreloxetine if the study data are found to be positive. The candidate enjoys the FDA’s Orphan Drug Designation status for the nOH indication in the United States.

Around mid-2025, Theravance agreed to sell its remaining royalty interest in net sales of Trelegy Ellipta to GSK for $225 million in cash. Following this, Theravance received a one-time cash payment of $225 million, significantly strengthening its balance sheet, reducing near-term financing risk, and extending its cash runway to advance pipeline development. Theravance held some royalty interest in GSK’s COPD medicine, Trelegy Ellipta.

Despite its solid cash position and growing collaboration revenues, Theravancefaces notable challenges that investors should watch closely. The company remains heavily dependent on profit-sharing income from Viatris for Yupelri, as it currently has no wholly-owned marketed products. Any disruption in this partnership or slower-than-expected sales growth could weigh on its top line. In addition, Theravance’s prospects hinge on the success of its late-stage candidate ampreloxetine, which has already faced clinical setbacks and enrollment delays in the ongoing late-stage study. A failure to achieve positive results or obtain regulatory approval would significantly limit TBPH’s near-term growth potential.

How Do Estimates Compare for CRMD & TBPH?The Zacks Consensus Estimate for CorMedix’s 2025 sales and earnings per share (EPS) implies a year-over-year increase of around 614% and 1,027%, respectively. However, EPS estimates for 2025 and 2026 have been trending downward over the past 60 days.

CRMD Estimate MovementImage Source: Zacks Investment Research

The Zacks Consensus Estimate for Theravance’s 2025 sales implies a year-over-year increase of around 65%. Its EPS estimate for 2025 is currently pegged at 24 cents. EPS estimates for both 2025 and 2026 have remained constant over the past 60 days.

TBPH Estimate MovementImage Source: Zacks Investment Research

Price Performance and Valuation of CRMD & MIRMIn the past six months, CRMD shares have plunged 48.9%, while TBPH shares have rallied 39.8%. In comparison, the industry has returned 22.8%, as seen in the chart below.

Image Source: Zacks Investment Research

From a valuation standpoint, Theravance is more expensive than CorMedix based on the price-to-book (P/B) ratio. TBPH shares currently trade at 4.19 times trailing book value, higher than 1.48 for CRMD.

Image Source: Zacks Investment Research

CRMD vs. TBPH: Which Stock is the Stronger Small-Cap Play?For investors seeking a small-cap biotech with visible earnings momentum and diversified growth potential, Theravance Biopharma, carrying a Zacks Rank #3 (Hold), is clearly the better pick over CorMedix, which currently carries a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Based on the above discussion, Theravance Biopharma appears to offer the more balanced risk-reward profile at this stage. Unlike CorMedix, which remains heavily dependent on a single product, TBPH benefits from a profit-sharing stream from Yupelri and a significantly strengthened balance sheet following the $225 million Trelegy royalty sale. That cash infusion reduces near-term financing risk and gives the company flexibility to advance its late-stage pipeline without immediate dilution concerns — a key advantage in the capital-intensive biotech space. Meanwhile, steady growth in collaboration revenues provides a measure of operating stability that many small-cap biotechs lack.

In contrast, CorMedix’s outlook has become uncertain as management signaled a more conservative trajectory for DefenCath, its primary revenue driver. Slowing growth expectations, pricing pressure and competitive risks create a narrower margin for error. TBPH, by comparison, combines growing collaboration income with a potentially transformative late-stage catalyst in ampreloxetine, supported by the Orphan Drug status and a clear regulatory pathway. For investors seeking a stronger small-cap play with diversified drivers and a fortified cash position, TBPH currently stands out as the more compelling pick in 2026 over CRMD.
2026-02-24 14:11 2mo ago
2026-02-24 09:06 2mo ago
Kratos Defense Q4 Earnings and Revenues Surpass Estimates stocknewsapi
KTOS
Key Takeaways KTOS reported Q4 adjusted EPS of 18 cents, up 38.5% year over year, topping estimates.Kratos Defense posted 21.9% revenue growth, with book-to-bill at 1.3-1 and backlog of $1.212B.KTOS ended 2025 with $560.6M cash, no long-term debt, and guided 2026 revenues of $1.595-$1.675B. Kratos Defense & Security Solutions, Inc. (KTOS - Free Report) reported fourth-quarter 2025 adjusted earnings of 18 cents per share, which beat the Zacks Consensus Estimate of 14 cents by 28.6%. The bottom line also increased 38.5% from the year-ago quarter’s 13 cents.

Kratos Defense reported GAAP earnings of 3 cents per share, which came in line with the year-ago quarter.

The company reported 2025 adjusted earnings of 55 cents per share, which were higher than the year-ago figure of 49 cents.

KTOS’ Total RevenuesTotal revenues were $345.1 million, which outpaced the Zacks Consensus Estimate of $328 million by 5.1%. The figure also rose 21.9% from $283.1 million recorded in the year-ago quarter.

The company reported total revenues of $1.35 billion in 2025, which were higher than $1.14 billion in 2024.

Operational Update of Kratos DefenseKratos Defense’s selling, general and administrative expenses increased 19% year over year. Research and development expenses decreased 7.5% compared with the prior-year quarter. Depreciation expenses climbed 68% year over year.

Expenses related to the amortization of intangible assets rose 9.5% from the year-ago figure.

The company reported operating income of $8.2 million, which increased from the year-ago quarter’s $3 million.

It posted a consolidated book-to-bill ratio of 1.3 to 1, with bookings worth $438.3 million.

The total backlog at the end of the fourth quarter was $1.212 billion compared with $1.178 billion at the end of the third quarter of 2025.

KTOS’ Segmental PerformanceUnmanned Systems: Revenues from this segment totaled $68.5 million compared with $61.1 million in the year-ago quarter.

Kratos Government Solutions: Revenues from this segment amounted to $276.6 million compared with $222 million in the year-ago quarter. The most notable growth in this segment was in the company’s Defense and Rocket Support business, Microwave Products business and Space, Training and Cyber businesses, with organic revenue growth rates of 47.4%, 32.4% and 22.7%, respectively, compared with the fourth quarter of 2024.

Financial Details of KTOSAs of Dec. 28, 2025, cash and cash equivalents totaled $560.6 million, up from $329.3 million as of Dec. 29, 2024.

The company reported no long-term debt as of Dec. 28, 2025 compared with $174.6 million recorded as of Dec. 29, 2024.

The net cash used in operating activities amounted to $42.1 million during 2025 against $49.7 million net cash provided at the end of 2024.

Kratos Defense’s GuidanceKTOS projects first-quarter 2026 revenues to be in the range of $335-$345 million. The Zacks Consensus Estimate for revenues is pegged at $348.5 million, higher than the company’s guided range.

KTOS expects 2026 revenues to be in the $1.595-$1.675 million range. The Zacks Consensus Estimate for revenues is pegged at $1.6 billion, which is at the lower end of the company’s guided range.

Kratos Defense expects operating cash flows to be in the range of $50-$60 million and free cash flow use to be in the band of $85-$95 million for 2026.

KTOS’ Zacks RankKratos Defense currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Defense ReleasesNorthrop Grumman Corporation (NOC - Free Report) reported fourth-quarter 2025 adjusted earnings of $7.23 per share, which topped the Zacks Consensus Estimate of $7 by 3.3%. The bottom line also increased 13.1% from $6.39 registered in the prior-year quarter.

NOC’s total sales of $11.71 billion in the fourth quarter beat the Zacks Consensus Estimate of $11.62 billion by 0.8%. The top line also rose 9.6% from $10.69 billion reported in the year-ago quarter.

L3Harris Technologies, Inc. (LHX - Free Report) reported fourth-quarter 2025 adjusted earnings (from continuing operations) of $2.86 per share, which surpassed the Zacks Consensus Estimate of $2.76 by 3.6%.

Revenues totaled $5.65 billion, which missed the Zacks Consensus Estimate of $5.79 billion by 2.6%. However, the top line improved 2.3% from the year-ago quarter’s $5.52 billion.

RTX Corporation’s (RTX - Free Report) fourth-quarter 2025 adjusted earnings per share (EPS) of $1.55 beat the Zacks Consensus Estimate of $1.46 by 5.9%. The bottom line also rose 0.6% from the year-ago quarter’s level of $1.54.

RTX’s fourth-quarter sales totaled $24.24 billion, which surpassed the Zacks Consensus Estimate of $22.74 billion by 6.6%. The top line also surged a solid 12.1% from $21.62 billion recorded in the fourth quarter of 2024.
2026-02-24 14:11 2mo ago
2026-02-24 09:07 2mo ago
KeyBank Recognized as Best Bank in Small Business and Middle Market Banking with Nine National and Regional Coalition Greenwich 2026 Awards stocknewsapi
KEY
Awards recognize Key's commitment to building relationships and enduring trust with clients, and providing excellent service  

, /PRNewswire/ -- KeyBank (NYSE: KEY) is being recognized for its support of small and middle market business clients with nine 2026 Best Bank Awards from Crisil Coalition Greenwich in small business and middle market banking. These national and regional awards honor Key's collaborative approach that empowers small business owner-operators in addressing their complex financial needs and depth of expertise that helps middle market companies optimize business performance.  

KeyBank received the following national Coalition Greenwich 2026 Awards:

2026 Coalition Greenwich Awards Best Bank: Trust for Middle Market Banking in the U.S. Customer Service for Middle Market Banking in the U.S. Customer Service for Small Business Banking in the U.S. Trust for Small Business Banking in the U.S. Ease of Doing Business for Small Business Banking in the U.S. Satisfaction with Relationship Manager for Small Business Banking in the U.S. KeyBank also received the following regional Coalition Greenwich 2026 Awards:

Best Bank: Satisfaction in Cash Management for Middle Market Banking in the U.S. (Midwest) Satisfaction with Relationship Manager for Middle Market Banking in the U.S. (Midwest) Satisfaction with Relationship Manager for Small Business Banking in the U.S. (Midwest) "Our unique approach of having conversations with and building enduring relationships with small business owners across the nation is a true differentiator for KeyBank," said Mike Walters, President of Business Banking at KeyBank. "We are grateful that our approach has been recognized by our clients through Coalition Greenwich; clients that we are proud to work with each day and help them grow in their communities."

Learn more about how KeyBank helps small businesses "We are honored to be recognized by our clients through Coalition Greenwich for the support and specialized service our middle market teams provide," said Ken Gavrity, President of Key Commercial Bank. "We are committed to earning our clients' trust by providing them with a best-in-class platform and deep industry expertise that empowers middle market businesses to grow and succeed."

Learn more about the solutions KeyBank offers to middle market businesses Methodology

Small Business: Awards are based on more than 11,000 interviews with businesses with sales of $1 million –$10 million across the country.

Middle Market Business: Awards are Based on nearly 11,000 interviews with businesses with sales of $10–500 million across the United States.

Source: Coalition Greenwich Voice of Client - 2025 U.S. Commercial Banking Study

ABOUT KEYCORP
KeyCorp's roots trace back more than 200 years to Albany, New York. Headquartered in Cleveland, Ohio, Key is one of the nation's largest bank-based financial services companies, with assets of approximately $184 billion at December 31, 2025.  

Key provides deposit, lending, cash management, and investment services to individuals and businesses in 15 states under the name KeyBank National Association through a network of approximately 950 branches and approximately 1,200 ATMs. Key also provides a broad range of sophisticated corporate and investment banking products, such as merger and acquisition advice, public and private debt and equity, syndications and derivatives to middle market companies in selected industries throughout the United States under the KeyBanc Capital Markets trade name. For more information, visit https://www.key.com/. KeyBank Member FDIC. 

CFMA #260220-4110928

SOURCE KeyBank

Also from this source
2026-02-24 14:11 2mo ago
2026-02-24 09:07 2mo ago
You Could Have Captured Gold's 73% Surge For Only 0.18% stocknewsapi
AAAU
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© ayala_studio / E+ via Getty Images

Gold has returned 73% over the past year and 18% year-to-date through February 20, 2026, outpacing most traditional asset classes. For investors asking whether they need dedicated gold exposure, Goldman Sachs Physical Gold ETF (NYSEARCA:AAAU) offers one of the most cost-efficient ways to get it.

What AAAU Is Built to Do AAAU holds physical gold bullion custodied at the Royal Canadian Mint, meaning each share represents a fractional claim on actual metal. There are no derivatives, no leverage, and no options overlay. The fund’s return engine is straightforward: when gold prices rise, so does the share price. When gold falls, so does the share price. This simplicity is the point. AAAU is designed to give investors direct gold price exposure at a low cost, making it a tool for portfolio diversification, inflation hedging, and safe-haven positioning rather than income generation.

Does It Deliver? The numbers confirm AAAU tracks gold faithfully. Over the past year, AAAU returned 73.1%, essentially matching SPDR Gold Shares (NYSEARCA:GLD)’s 72.9% over the same period. The marginal difference is largely explained by AAAU’s 0.18% expense ratio, which is meaningfully lower than GLD’s 0.40%, giving AAAU a structural cost advantage over the long run for buy-and-hold investors.

The interest rate environment has shifted meaningfully in gold’s favor. The Federal Reserve has cut rates over the past year, and the 10-year Treasury yield has retreated from its 2025 highs to sit around 4.08% as of February 19. When real yields fall, the opportunity cost of holding non-yielding gold declines — historically one of the strongest tailwinds for gold prices, and a key reason AAAU’s returns have been so strong in this cycle.

The Tradeoffs AAAU pays no dividend and generates no income. Investors who need yield from every portfolio position will find it a poor fit. Gold also carries no earnings growth or cash flow, meaning its price is driven entirely by sentiment, monetary conditions, and demand dynamics rather than fundamental business value.

Tax treatment is also worth understanding. The IRS classifies physical gold ETFs as collectibles, which means long-term capital gains are taxed at a maximum rate of 28% rather than the standard 20% rate applied to most equity ETFs. For taxable accounts, this is a meaningful cost that can erode after-tax returns versus holding an equivalent equity position.

Gold has historically served as a portfolio diversifier and inflation hedge. Investors should consult a financial advisor to determine whether gold exposure fits their individual circumstances.
2026-02-24 14:11 2mo ago
2026-02-24 09:07 2mo ago
Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call Transcript stocknewsapi
BOEUF
Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call Transcript
2026-02-24 14:11 2mo ago
2026-02-24 09:08 2mo ago
Hub Group Investigated for Securities Fraud Amid Accounting Restatements; Investors Encouraged to Contact Block & Leviton to Possibly Recover Losses stocknewsapi
HUBG
Boston, Massachusetts--(Newsfile Corp. - February 24, 2026) - Block & Leviton is investigating Hub Group, Inc. (NASDAQ: HUBG) for potential securities law violations. Investors who have lost money in their Hub Group investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/hubg.

What is this all about?

Shares of Hub Group fell more than 20% in intraday trading on February 5, 2026, after the company identified an accounting error related to the recording of purchased transportation costs, which resulted in an understatement of accounts payable of approximately $77 million. The company stated that the error impacts previously issued financial statements and that it will delay the filing of its Form 10-K while it completes a restatement. Block & Leviton is investigating.

Who is eligible?

Anyone who purchased Hub Group common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (888) 256-2510.

Whistleblower?

If you have non-public information about Hub Group, you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [email protected] or by phone at (888) 256-2510.

Why should you contact Block & Leviton?

Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email [email protected] with any questions.

This notice may constitute attorney advertising.

CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (888) 256-2510
Email: [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/285075

Source: Block & Leviton LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-24 14:11 2mo ago
2026-02-24 09:09 2mo ago
Agroz Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency stocknewsapi
AGRZ
, /PRNewswire/ -- Agroz Inc. (NASDAQ: AGRZ) ("Agroz" or the "Company"), an innovative, fully vertically integrated agricultural technology company designing, building, managing, and operating indoor Controlled Environment Agriculture vertical farms, today announced that it received a deficiency letter ("Deficiency Letter") from the Listing Qualifications Department (the "Staff") of The Nasdaq Capital Market ("Nasdaq") notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company's Ordinary Shares, par value $0.0001 per share (the "Ordinary Shares"), was below the minimum $1.00 per share requirement for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Requirement").

The Company's receipt of this Deficiency Letter has no immediate effect on the Company's Nasdaq listing. In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or until August 17, 2026 (the "Compliance Date", and such 180 day period, the "Compliance Period"), to regain compliance with the Bid Price Requirement. If at any time during the Compliance Period the closing bid price of the Ordinary Shares is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide the Company with written confirmation of compliance and thismatter will be closed.

If the Company does not regain compliance during the Compliance Period, the Company may be eligible for an extension of an additional 180 calendar days, provided that the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq except for the Bid Price Requirement, and provide a written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company chooses to implement a reverse stock split, it must complete such split no later than ten (10) business days prior to the Compliance Date. If it appears to the Staff that the Company will not be able to cure its deficiency, or if the Company is otherwise not eligible, Nasdaq will notify the Company of its determination to delist the Company's Ordinary Shares, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel.

The Company intends to monitor the closing bid price of the Common Shares and may, if appropriate, consider available options to regain compliance with the Bid Price Requirement.

About Agroz Inc.

Agroz Inc. is an innovative, fully vertically integrated agricultural technology company designing, building, managing, and operating indoor and outdoor Controlled Environment Agriculture ("CEA") vertical farms. Agroz also operates CEA vertical farms in local communities to grow and deliver clean, pesticide free, fresh and nutritious rich vegetables directly to consumers and businesses, and to educate the public on how its vegetables are grown. Agroz believes its competitive advantage stems from its proprietary Agroz OS system, a vertical farm operating system comprised of (i) digitally automated hardware systems enabling management of vertical farm conditions, and (ii) certain software solutions enabling email and communication systems for vertical farm organization. 

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking statements." You can identify forward-looking statements as those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. The reader is cautioned not to rely on these forward-looking statements. Actual results could vary materially from the expectations and projections of Agroz. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including, without limitation, statements regarding the closing of the Offering and the use of proceeds from the sale of our ordinary shares in the Offering. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking statements discussed in this press release and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us more fully described in Agroz's filings with the SEC. We do not undertake to update any forward-looking statement as a result of new information or future events or developments, except as required by U.S. federal securities laws.

SOURCE Agroz Inc
2026-02-24 14:11 2mo ago
2026-02-24 09:09 2mo ago
Conduent data breach grows, affecting at least 25M people stocknewsapi
CNDT
The spillover from a ransomware attack on one of the largest government contractors in the United States keeps getting bigger: more than 25 million people have now had personal data stolen in the hack.

Conduent provides printing, mailroom services, and document and payment processing services for state government benefit operations, such as food assistance, as well as workplace and unemployment benefits for large corporations. As such, the company handles a large amount of personal information belonging to a large swath of the United States. Conduent says its technology and operational support services reach more than 100 million people.

But since the January 2025 cyberattack attack, which a ransomware group claimed credit for, the corporate giant has said little about the data breach, such as how it was caused and how many people are affected.

An update to the state of Wisconsin’s data breach notification page now shows the Conduent breach affects at least 25 million people across the United States.

TechCrunch’s ongoing tally from various data breach notification letters that we have seen also amounts to about 25 million people, with Oregon (10.5 million) and Texas (15.4 million) accounting for the majority of those affected. Other data breach notices seen by TechCrunch include another few hundred thousand individuals across Massachusetts, New Hampshire and Washington.

The breach is known to have compromised individuals’ names, dates of birth, addresses, Social Security numbers, health insurance information, and medical data.

Conduent has said little outside of its data breach notifications, and in some cases has made it more difficult for affected individuals to learn about the breach.

Techcrunch event

Boston, MA | June 9, 2026

A page on Conduent’s website, titled “Incident Notice” that was published in October 2025 at the same time as its first data breach notification, does not explicitly mention a cybersecurity incident. The page contains a hidden “noindex” tag in its source code, which tells search engines to not list the page in search results, making it difficult for anyone searching the web to find it.

When reached by TechCrunch, Conduent spokesperson Sean Collins would not say how many notifications the company has sent to date, or why the company is hiding its incident notice from search engines.

Conduent’s breach has been billed as one of the “largest ever,” but likely trails behind the Change Healthcare hack, which affected more than 190 million people following a ransomware attack in February 2024. A Russian-speaking ransomware gang stole reams of health and medical data from Change Healthcare using a stolen credential that wasn’t protected with multi-factor authentication, prompting the healthcare tech giant to pay at least two ransoms to keep most of the stolen data off the internet.

Zack Whittaker is the security editor at TechCrunch. He also authors the weekly cybersecurity newsletter, this week in security.

He can be reached via encrypted message at zackwhittaker.1337 on Signal. You can also contact him by email, or to verify outreach, at [email protected].
2026-02-24 13:11 2mo ago
2026-02-24 08:00 2mo ago
Tesla: Decommissioning Legacy Auto To Birth The AI Economy stocknewsapi
TSLA
Tesla, Inc. remains a Buy as it aggressively pivots into a vertically integrated physical AI utility, targeting the Energy-Compute-Labor loop. TSLA is reallocating assets from legacy auto lines to scale Optimus and Cybercab, aiming for a TAM beyond transportation and margin expansion via AI and energy. Key risks include a Hardware-AI Capital Intensity Trap, with $20B+ FY2026 CapEx potentially outpacing revenue, and regulatory/tariff headwinds compressing margins.
2026-02-24 13:11 2mo ago
2026-02-24 08:00 2mo ago
Nvidia earnings report collides with Wall Street skepticism over AI spending stocknewsapi
NVDA
It's been a tough start to the year for technology investors. Shares of seven of the eight trillion-dollar tech companies have notched losses so far.

The lone exception is Nvidia. The chipmaker's stock is up 2.7% in 2026 as of Monday's close, while the Nasdaq has dropped more than 2.5%. Microsoft, Amazon and Tesla have all seen double-digit declines.

Heading into Nvidia's quarterly earnings report Wednesday, Wall Street has a pretty clear idea of where the company stands. That's because its biggest customers announced results a few weeks ago and told investors that their mammoth spending on artificial intelligence infrastructure is only going to increase.

"Hyperscale capex forecasts for CY2026 have exceeded prior expectations," analysts at Wedbush Securities wrote in a Monday note previewing Nvidia's earnings. "With servers and AI infrastructure representing the bulk of forward spend, we expect growth in AI investment will somewhat exceed overall capex trends."

Like over 90% of firms tracked by FactSet, Wedbush analysts recommend buying Nvidia shares. They have a $230 price target on the stock, which is 20% above Monday's close.

Read more CNBC tech newsAI robots may outnumber workers in a few decades, ex-Citi executive saysGoogle spinout Aalyria valued at $1.3 billion as investors pour into space-based communicationsSam Altman defends AI resource usage: Water concerns 'fake,' and 'humans use energy too'Microsoft Xbox chief Phil Spencer retires, replaced by AI executive Asha SharmaNvidia, the world's most valuable publicly traded company, now gets roughly 90% of its revenue from its data center business, which houses the graphics processing units, or GPUs, and AI systems used to train and run most large language models. As tech giants build massive new data centers to meet soaring demand, they're packing those facilities with Nvidia's latest and greatest products.

Alphabet, Microsoft, Meta and Amazon are expected to spend nearly $700 billion combined this year to fuel their AI expansion, according to their latest forecasts and analyst estimates. The four hyperscalers are projected to increase capital expenditures by more than 60% from the historic levels reached in 2025.

While all that spending is unquestionably positive for Nvidia, there are plenty of skeptics who fear that the tech industry is overbuilding, and that any slowdown or softness will have an outsized effect on the dominant chipmaker.

"The story is so unbelievably simple, yet at the same time quite complex today," wrote analysts at Cantor Fitzgerald in a report last week. The analysts, who have an outperform rating on the stock, said that despite "insatiable" demand for computing power and an "extremely positive" setup for Nvidia results, "investor concerns remain, headlined by fears of peaking hyperscale" capex this year.

watch now

Analysts on average expect Nvidia to report a 68% revenue jump to $66 billion for the fiscal fourth quarter, according to LSEG. For the April quarter, they see year-over-year growth of 63% to $72 billion.

Excitement is building for the upcoming release of Nvidia's next-generation Vera Rubin rack-scale systems later this year. CEO Jensen Huang said in October that 6 million Blackwell GPUs had been shipped in the past four quarters, and that Nvidia expects $500 billion in GPU sales between the Blackwell generation and the forthcoming Rubin chips.

Investors will be listening closely for commentary surrounding the rollout of Vera Rubin systems as they look to gauge demand for the rest of 2026 and beyond.

Another key topic for Huang and management to address is Groq.

Wednesday's earnings call will be the first since Nvidia purchased assets from the chip startup in late December for about $20 billion. With the deal, Groq founder and CEO Jonathan Ross along with Sunny Madra, the company's president, and other senior leaders joined Nvidia.

Groq's specialty is on the inference side of the market, which refers to the use of AI to make decisions based on new information. Nvidia dominates the training piece of the market, which involves teaching AI models to learn from patterns in large amounts of data. Analysts will be looking for clarity on the impact of the deal on Nvidia's balance sheet and its strategic plans for using the technology to compete with makers of custom ASICs, or application-specific integrated circuits.

"We are looking for any hints or specifics around products we should expect from Jonathan's team and how this acquisition will augment NVDA's accelerator business," the Wedbush analysts wrote. "With concerns around increased competition from ASIC solutions, in our view, being one of the greatest drags on NVDA's performance, we believe a strong Groq related roadmap could meaningfully allay investor concerns."

watch now
2026-02-24 13:11 2mo ago
2026-02-24 08:01 2mo ago
Skyworks to Present at the Morgan Stanley Technology, Media & Telecom Conference stocknewsapi
SWKS
IRVINE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed-signal semiconductors connecting people, places and things, today announced that executives will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco at 8:30 a.m. PST on March 2, 2026.

The event will be webcast live and archived for replay for one week following the conference in the “Investors” section of Skyworks’ website at www.skyworksinc.com.

About Skyworks
Skyworks Solutions, Inc. is empowering the wireless networking revolution. We are a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, including aerospace, automotive, broadband, cellular infrastructure, connected home, defense, entertainment and gaming, industrial, medical, smartphone, tablet and wearables.

Skyworks is a global company with engineering, marketing, operations, sales and support facilities located throughout Asia, Europe and North America and is a member of the S&P 500® market index (Nasdaq: SWKS). For more information, please visit Skyworks’ website at: www.skyworksinc.com.

Safe Harbor Statement
Any forward-looking statements contained in this press release are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include without limitation information relating to future events, results and expectations of Skyworks. Forward-looking statements can often be identified by words such as “anticipates,” “expects,” “forecasts,” “intends,” “believes,” “plans,” “may,” “will” or “continue,” and similar expressions and variations or negatives of these words. Actual events and/or results may differ materially and adversely from such forward-looking statements as a result of certain risks and uncertainties, including those identified in the “Risk Factors” section of Skyworks' most recent Annual Report on Form 10-K (and/or Quarterly Report on Form 10-Q) as filed with the Securities and Exchange Commission (“SEC”). Copies of Skyworks' SEC filings can be obtained, free of charge, on Skyworks' website (www.skyworksinc.com) or at the SEC's website (www.sec.gov). Any forward-looking statements contained in this press release are made only as of the date hereof, and we undertake no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Note to Editors: Skyworks and the Skyworks symbol are trademarks or registered trademarks of Skyworks Solutions, Inc., or its subsidiaries in the United States and other countries. Third-party brands and names are for identification purposes only and are the property of their respective owners.
2026-02-24 13:11 2mo ago
2026-02-24 08:01 2mo ago
WEBTOON SHAREHOLDER ALERT: Kaskela Law Firm Announces Investigation of WEBTOON Entertainment Inc. and Encourages Long-Term Shareholders to Contact the Firm – WBTN stocknewsapi
WBTN
PHILADELPHIA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Shareholder protection firm Kaskela Law announces that it is investigating potential breach of fiduciary duty claims concerning WEBTOON Entertainment Inc. (NASDAQ: WBTN) on behalf of the company’s long-term shareholders.

Click here to request additional information: https://kaskelalaw.com/case/webtoon/

Recently a securities fraud complaint was filed against WEBTOON on behalf of certain investors who purchased shares of the company’s stock prior to August 9, 2024.

On or around June 28 2024, WEBTOON completed its initial public offering (“IPO”) of common stock, selling 15 million shares of stock to investors at a price of $21.00 per share, for proceeds of approximately $315 million.

According to the complaint, on August 8, 2024, WEBTOON reported disappointing quarterly financial and operational results for the reporting quarter ended June 30, 2024 – the quarter that closed just one business day after the IPO. Among other things, that quarterly report disclosed “bleak revenue growth and substantial declines” in Monthly Active Users (“MAUs”) for the relevant quarter. Following this quarterly report, shares of WEBTOON’s stock fell $7.88 per share, or over 38% in value, to close on August 9, 2024 at $12.75 per share, on unusually heavy trading volume.

The investigation seeks to determine whether the members of WEBTOON’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct.  

WEBTOON shareholders who have owned their WBTN shares since at least August 8, 2024 are encouraged to click here to fill out our online form, or contact lead investigative attorney Adrienne Bell, Esq. at (484) 229 – 0750 or by email at [email protected]. You can also click on the following link or paste it into your browser to learn more about the investigation and your legal rights and options:

https://kaskelalaw.com/case/webtoon/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent (no recovery, no cost) basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com, or contact us today at (888) 715 – 1740.

KASKELA LAW LLC  
D. Seamus Kaskela, Esq.  
Adrienne Bell, Esq.    
18 Campus Blvd., Suite 100  
Newtown Square, PA 19073  
(888) 715 – 1740  
(484) 229 – 0750  
www.kaskelalaw.com  

This notice may constitute attorney advertising in certain jurisdictions.  
2026-02-24 13:11 2mo ago
2026-02-24 08:01 2mo ago
Micron's $100 billion New York semiconductor manufacturing project is facing local pushback stocknewsapi
MU
On a snowy Friday in January, dignitaries from both political parties braved the chill of a central New York winter for the groundbreaking ceremony of Micron Technology’s planned $100 billion manufacturing complex in Clay, a town not far from Syracuse. Over the next 20 years, Micron is promising the region thousands of jobs and the revitalization of a community hard hit by the decline of manufacturing.

Since President Joe Biden signed the CHIPS and Science Act in 2022, billions of public dollars have flowed into domestic semiconductor manufacturing as the United States seeks to revitalize an industry that was born in the U.S. before it was largely outsourced to East Asia. Both Democrats and Republicans have argued that domestic chip production is essential to national security, citing the role advanced semiconductors play in military systems as well as in critical infrastructure like financial and telecommunications networks.

In order to expedite the development of up to four fabrication plants in central New York state, Micron may receive as much as $25 billion in public subsidies, including $6.1 billion from the federal CHIPS Act, $5.5 billion from New York state and billions more in refundable manufacturing tax credits.

But some residents and advocates question whether the Micron project, as it’s currently planned, will bring more harm than good. The facility will consume vast amounts of water and energy while producing substantial hazardous waste, according to the company’s environmental impact statement. Emissions and contaminated wastewater and soil from the notoriously dirty semiconductor industry pose potential environmental and health risks for surrounding areas, while exposure to its toxic chemicals has been linked to cancers and reproductive harm. Community members want enforcement measures to ensure the company follows through on promised environmental safeguards and its pledge to create 9,000 jobs.  

“We’re not trying to stop any progress, but we don’t want this just bulldozed into our area,” said Gracia Roulan, a nurse practitioner who has lived in Clay all her life and is part of the local group Neighbors for a Better Micron. Roulan said advocates like her want to ensure the project is “truly better for the community,” and raised concerns about potential pollution of the local water system and the clearing of the “beautiful marshes all around the area,” which provide a home to endangered species. To make way for the new structures, the project will fill more than 200 acres of wetlands. 

For its part, the company touts the project’s benefits to the region, including a promise to invest hundreds of millions of dollars in education, worker training and affordable housing over the next two decades. “Micron is committed to being a great member of the community and a responsible environmental steward,” Anna Newby, a Micron spokesperson, said in an email to Capital & Main. The company has committed to developing new wetlands to offset those that will be destroyed. Newby said the environmental review process Micron undertook for its central New York project was “thorough.” 

Yet just hours before Micron broke ground, Neighbors for a Better Micron, alongside national worker advocacy group Jobs to Move America, filed a lawsuit against the project in New York Supreme Court for Albany County, arguing that the state permitting process was “unnecessarily rushed” and did not adequately consider public input.
2026-02-24 13:11 2mo ago
2026-02-24 08:02 2mo ago
MN8 Energy ​Supports ​Meta's U.S. Data Center ​Operations​ with 80 MW Solar Project in Pennsylvania stocknewsapi
META
NEW YORK--(BUSINESS WIRE)-- #AI--MN8 Energy LLC, a New York-based leading renewable energy and battery storage company, today announced that it has entered into a long-term power purchase agreement with Meta, under which Meta will acquire the offtake generated by MN8's 80-megawatt (MW) Walker Solar Project in Juniata County, Pennsylvania. This transaction represents the first agreement between the two companies. Meta will purchase 100 percent of the offtake generated by the project to support its eff.
2026-02-24 13:11 2mo ago
2026-02-24 08:03 2mo ago
Kennametal Launches "Machinist of the Year" Global Program to Honor Long-Time Customers and Industry Leaders stocknewsapi
KMT
, /PRNewswire/ -- Kennametal Inc. (NYSE: KMT), a global leader in metal cutting solutions, today announced the launch of its Machinist of the Year program, a new annual initiative designed to recognize the skill, dedication and innovation of long-time machinist customers across every region. Winners will be announced in the Americas, EMEA, APAC and India.

"Machinists are the backbone of manufacturing," said Eddie McBarnett, Kennametal's Vice President of Marketing & Strategy. "Kennametal's innovations have always been driven by the needs of these skilled professionals with tooling solutions that cut faster, last longer and help shops achieve greater precision and profitability."

The Machinist of the Year program celebrates this enduring partnership by celebrating machinists who embody craftsmanship and innovation. Teams in the Americas, EMEA, APAC and India will each recognize a machinist who showcases the very best of their region's machining excellence.

"Our global search for Machinists of the Year is more than a contest—it's a celebration of the partnerships and expertise that drive our industry forward," said Scott Etling, Vice President of Product Marketing Management.

To enter, participants should post a brief, compelling video on their own social media channels, sharing how they use Kennametal products and why they should be selected as "Machinist of the Year." Entrants must tag Kennametal, include the hashtag #KMTMachinist and have been actively using Kennametal products at their workshop for at least the past year. Finalists will be selected regionally by the company's marketing teams in each region, and final voting will be open to the public on Kennametal's social media channels.

Each regional winner will receive the following:

Feature on Kennametal's website, blog and social media channels Award package including exclusive signage and merchandise $7,500 (USD equivalent) in branded "Machinist of the Year" Toolbox and Kennametal tooling Invitation to lead live machining demonstrations at a global trade show (IMTS, AMB, JIMTOF, IMTEX/AMTEX, as applicable) Automatic designation as a Kennametal Brand Ambassador Timeline

February 2026 — Official program launch June 2026 — Regional nominees announced, voting begins September/October 2026 — Regional winners revealed at trade shows and online For full details, submission guidelines and voting information, visit Kennametal's Machinist of the Year page.

About Kennametal
With over 85 years as an industrial technology leader, Kennametal Inc. delivers productivity to customers through materials science, tooling and wear-resistant solutions. Customers across aerospace and defense, earthworks, energy, general engineering and transportation turn to Kennametal to help them manufacture with precision and efficiency. Every day approximately 8,100 employees are helping customers in nearly 100 countries stay competitive. Kennametal generated $2 billion in revenues in fiscal 2025. Learn more at kennametal.com. Follow @Kennametal: Instagram, Facebook, LinkedIn and YouTube.

SOURCE Kennametal Inc.
2026-02-24 13:11 2mo ago
2026-02-24 08:03 2mo ago
Allstate expands year‑round identity protection, introduces industry‑first tools to help protect tax refunds stocknewsapi
ALL
Key takeaways:

Allstate reports identity theft cases increased 50% over the past two tax seasons, with adults in their 20s reporting more cases than other generations. Allstate Identity Protection plans safeguard customers' personal information with around-the-clock monitoring to detect fraud and restore identities as identity theft risks rise. Allstate's industry-first stolen tax refund advance gives customers access to their expected refund money if someone files a fraudulent return and claims it first. , /PRNewswire/ -- Allstate helps safeguard customers' identities with continuous monitoring, fraud detection and identity restoration. With tax season bringing heightened risk, the Allstate Identity Protection Blue Plan includes a first‑of‑its‑kind stolen tax refund advance to help customers access their expected refund if fraud strikes.

Allstate helps safeguard customers’ identities with continuous monitoring, fraud detection and identity restoration. "Allstate protects customers' identities every day with 24/7 monitoring to quickly detect fraud and hands-on support the moment you open a case," said Caroline Slane, senior vice president of business operations at Allstate Identity Protection. "During tax season, that protection extends to stolen refunds. We help customers access their money while we support them through recovery."

What identity threats should taxpayers watch for in 2026?
Identity theft thrives during tax season because more personal data circulates following the busy holiday shopping season. The rise in AI makes scams more convincing and scalable.

Allstate claims data from the 2025 tax season shows significant year-over-year increases in multiple types of identity theft compared with the 2024 tax season:1

Total identity theft cases: up 50% New credit account identity theft: up 45% Fraudulent applications for loans, credit cards or other financial products: up 65% Federal Trade Commission data shows adults in their 20s report five times more identity theft incidents than adults in their 70s.2

How can taxpayers protect their identity?
Allstate recommends people take these steps to protect their identity during tax season:

Avoid filing taxes on public Wi-Fi or using someone else's device Stay aware of phishing texts, suspicious DMs and social media scams Use reputable tax-filing software File taxes early before fraudsters even have the chance to file in their name What does Allstate Identity Protection include?
Allstate Identity Protection plans offer full-service identity restoration and tools to help members safeguard their personal information and detect fraud. Members receive monitoring, alerts and hands-on support from restoration specialists along with seasonal guidance to avoid tax-related scams. Consumers can enroll directly in individual or family plans at allstateidentityprotection.com or through employer benefit programs.

How does Allstate's stolen tax refund advance work?
Many taxpayers rely on their refund to manage expenses or pay down debt. The IRS expects larger refunds for many filers this year, increasing the impact when fraud occurs. The stolen tax refund advance is exclusive to Allstate and gives eligible customers their expected refund amount upfront, typically delivered within a few business days of filing a claim. The expected refund amount is calculated using tax-filing information the customer provides and verified identity protection data. Customers pay back Allstate over time with no interest.

How can consumers enroll in Allstate Identity Protection?
With more threats rising at once, consumers need protection on every front. Consumers can enroll directly in the Allstate Identity Protection Blue Plan or check if they already have access through one of Allstate's employer-provided plans, which covers more than 1.4 million employees and their families. Consumer plans start at $19 per month, coverage begins immediately, and first‑time customers receive the first 30 days free.

Editor's note
1 Based on Allstate Identity Protection identity theft incidents reported between January through April 2025, compared with January through April 2024.
2 According to FTC reports stored in the Consumer Sentinel Network.

About Allstate 
The Allstate Corporation (NYSE: ALL) protects people from life's uncertainties with a wide array of protection for autos, homes, electronic devices, and identities. Products are available through a broad distribution network including Allstate agents, independent agents, major retailers, online, and at the workplace. Allstate has more than 210 million policies in force and is widely known for the slogan "You're in Good Hands with Allstate." For more information, visit www.allstate.com.

SOURCE Allstate Insurance Company
2026-02-24 13:11 2mo ago
2026-02-24 08:03 2mo ago
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference stocknewsapi
CPRX
CORAL GABLES, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, being held in Miami, Florida.

Presentation Details
Date: Tuesday, March 10, 2026
Presentation: 3:30 PM ET
Webcast Link

The webcast will be available under the Investors section on the Company's website, www.catalystpharma.com, and a replay will be available for at least 30 days.

About Catalyst Pharmaceuticals
Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence, which remains the cornerstone of our commercial strategy, while continuously evaluating strategic opportunities to expand our global footprint. Catalyst, headquartered in Coral Gables, Fla., has been recognized by Forbes as one of America’s Most Successful Company in 2023, 2024, and 2025, and on the 2025 Deloitte Technology Fast 500™ list as one of North America’s Fastest-Growing Companies.

For more information, please visit Catalyst's website at www.catalystpharma.com. 

Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst's actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst's Annual Report on Form 10-K for the fiscal year 2024 and its subsequent filings with the U.S. Securities and Exchange Commission (“SEC”), could adversely affect Catalyst. Copies of Catalyst's filings with the SEC are available from the SEC, may be found on Catalyst's website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.

Source: Catalyst Pharmaceuticals, Inc.
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update stocknewsapi
RIGL
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday, March 3, 2026.
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston stocknewsapi
CADL
February 24, 2026 08:05 ET  | Source: Candel Therapeutics

NEEDHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and Chief Executive Officer, will present at TD Cowen’s 46th Annual Health Care Conference, being held on March 2-4, 2026 in Boston, MA.

Presentation Details:

Date: Tuesday, March 3, 2026

Time: 11:50 AM - 12:20 PM ET

Webcast Link: TD Cowen / Candel Presentation

A webcast of the presentation will be available by selecting Events and Presentations under the News & Events tab in the Investors section at www.candeltx.com. A replay of the webcast will be archived for up to 90 days following the session date.

About Candel Therapeutics

Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. Aglatimagene besadenovec (CAN-2409 or aglatimagene) is the lead product candidate from the adenovirus platform. The Company recently completed successful phase 2a clinical trials of aglatimagene in non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and a pivotal, placebo-controlled, phase 3 clinical trial of aglatimagene in localized prostate cancer, conducted under a Special Protocol Assessment agreed with the U.S. Food and Drug Administration (FDA). The FDA also granted Fast Track Designation and Regenerative Medicine Advanced Therapy Designation to aglatimagene for the treatment of newly diagnosed localized prostate cancer in patients with intermediate-to-high-risk disease, Fast Track Designation in NSCLC, and both Fast Track Designation and Orphan Drug Designation to aglatimagene for the treatment of PDAC.

Linoserpaturev (CAN-3110) is the lead product candidate from the HSV platform and is currently in an ongoing phase 1b clinical trial in recurrent high-grade glioma, evaluating the effects of repeat linoserpaturev injections. Initial results were published in Nature and Science Translational Medicine and linoserpaturev received Fast Track Designation and Orphan Drug Designation from the FDA. Finally, Candel’s enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.

For more information about Candel, visit: www.candeltx.com.

Forward-Looking Statements

This press release includes certain disclosures that contain “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of current and future development programs; expectations regarding the therapeutic benefit of the Company’s platforms, including the ability of its platforms to improve overall survival and/or disease-free survival of patients living with difficult-to-treat, solid tumors; and expectations regarding the potential benefits conferred by regulatory designations. The words “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; expectations regarding the therapeutic benefit of the Company’s programs; that final data from the Company’s preclinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; the Company’s ability to efficiently discover and develop product candidates; the Company’s ability to obtain and maintain regulatory approval of product candidates; the Company’s ability to maintain its intellectual property; the implementation of the Company’s business model, including strategic plans for the Company’s business and product candidates; the impact of the Company’s existing and any future indebtedness on its ability to operate its business; the Company’s ability to access any future tranches under its debt facility and to comply with all of its obligations thereunder; and other risks identified in the Company’s filings with the U.S. Securities and Exchange Commission (SEC), including the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, each as filed with the SEC and any subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company’s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date.

Investor Contact
Theodore Jenkins
Vice President, Investor Relations, and Business Development
Candel Therapeutics, Inc.
[email protected]

Media Contact
Ben Shannon
ICR Healthcare
[email protected]
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery stocknewsapi
MXCT
February 24, 2026 08:05 ET  | Source: MaxCyte, Inc

ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced the launch of ExPERT DTx™, a new high throughput transfection platform for research and drug discovery applications. This modular, 96-well electroporation system enables labs to transfect primary cells and cell lines with minimal cellular stress, helping researchers to uncover valuable insights and better understand fundamental biological processes before scaling up to larger transfection volumes.

ExPERT DTx streamlines workflows by processing up to 96 samples in a single, three-minute run. The platform’s R-50x96™ well processing assembly provides one of the most cost-effective solutions for 96-well electroporation on the market, allowing 12 detachable 8-well strips to be processed in parallel with unique parameters for different cell and cargo combinations. This ensures consistent well-to-well performance that effectively eliminates transfection as an experimental variable, while maximizing flexibility and reducing laboratory waste. It has been validated in a range of applications – from cell and gene therapy development to protein production – and enables the transfer of optimized processes to other ExPERT instruments, simplifying scale-up from discovery into cGMP-compliant manufacturing without the need to reoptimize workflows.

One of the defining features of the platform is its efficient and user-friendly software package. The DTx Software controls and monitors the instrument, while the DTx Designer software introduces a distinct advantage over current options on the market, enabling users to design their experiments remotely, then upload the workflow when the system is available for use. This maximizes uptime, and is especially beneficial to labs running multiple, back-to-back experiments.

“We’re extremely excited about the launch of the ExPERT DTx, which builds on the company’s established portfolio of best-in-class electroporation technologies,” said Maher Masoud, Chief Executive Officer of MaxCyte. “This cutting-edge platform provides researchers with deep insights into their experiments, helping them investigate the underlying biology of a cellular system before scaling up operations with confidence. We’ve developed this product around our customers’ needs, giving them the flexibility needed for research while delivering reproducible results with high cell viability at an affordable price.”

For more information about ExPERT DTx, please visit: https://maxcyte.com/electroporation-systems/dtx/

About MaxCyte

At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQure DX® gene editing risk assessment services enable precise, efficient and scalable cell engineering. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers from around the world to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we’ve been advancing cell engineering, shaping the future of medicine. Learn more at maxcyte.com and follow us on X and LinkedIn.

MaxCyte Contacts:

Investor Relations
Gilmartin Group
David Deuchler, CFA
[email protected]

Media Contact
Oak Street Communications
Kristen White
+1 415-608-6060
[email protected]
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
NAPC Defense Announces Contract Awards of $38 Million stocknewsapi
BLIS
CLEARWATER, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- NAPC Defense, Inc. (OTCID: BLIS) (“NAPC Defense” or “the Company”), a U.S. licensed defense manufacturer with exclusive rights to produce and distribute the CornerShot USA system, announced today that it has received $38,166,873.04 in new and recently finalized U.S. government task orders through its strategic partner Obera LLC (“Obera”) under existing U.S. Department of Defense and Department of State contract vehicles, with performance extending into the 2032 timeframe.

These awards were Obera’s hard backlog, which represent sales between now and January 2027, and sit within a broader set of Indefinite Delivery, Indefinite Quantity (IDIQ) contracts that have the potential to provide a much larger available contract ceiling through the end of 2032.

Obera is a prime and subcontractor on major U.S. government contract vehicles supporting global logistics, training, systems integration, and sustainment missions for the Department of Defense and Department of State, including NAVSUP WEXMAC, ACC AMIC CNGT, and DOS GLOBALCAP programs. Its work spans security assistance, supply-chain management, sustainment operations, and information management in complex operating environments worldwide.

“This Obera transaction represents our first major award platform and positions NAPC Defense to build a profitable, sustained U.S. government contracting business for at least the next six years,” said Edward K. West, Chief Executive Officer of NAPC Defense. “We intend to grow from this foundation into a major American defense contractor serving U.S. and allied missions around the world. God bless America.”

In addition to the Obera portfolio, NAPC Defense is pursuing new purchase orders from U.S. and allied customers as the Sole Source for the CornerShot tactical systems, as well as ammunition initiatives, which are expected to complement the long-term, contract-based revenue stream provided by Obera’s U.S. government programs.

About NAPC Defense, Inc.

NAPC Defense, Inc. (OTCID: BLIS) is a U.S.-licensed armament sales and production company with exclusive rights to manufacture and distribute the CornerShot USA weapons system. The Company brokers defense articles and munitions worldwide, with all activities conducted under applicable U.S. State Department and federal regulatory approvals.

As the exclusive U.S. producer and distributor of the CornerShot USA platform, NAPC Defense is committed to delivering innovative, lifesaving technologies that enhance officer survivability and protect communities in high-risk environments.

For further information, please go to napcdefense.com

Forward-looking statements

This press release and statements by representatives of NAPC Defense, Inc. may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including, but not limited to, statements regarding the Company’s plans, objectives, expectations, strategies, and future performance. These statements are based on current assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including those described in the Company’s periodic reports filed with the U.S. Securities and Exchange Commission. NAPC Defense undertakes no obligation to update forward-looking statements, except as required by law.

Investor and media contact

Media Inquiries and Demonstration Requests
Kenny West, Chief Executive Officer
NAPC Defense, Inc.
Phone 754 242 6272 ext. 713
[email protected]
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
Preferred Hotels & Resorts Welcomes Wynn Al Marjan Island to its Esteemed Legend Collection stocknewsapi
WYNN
LONDON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Preferred Hotels & Resorts is pleased to announce the addition of Wynn Al Marjan Island to its prestigious Legend Collection, marking a significant milestone ahead of the resort’s highly anticipated opening in Spring 2027. Located less than 50 miles from Dubai International Airport in the Emirate of Ras Al Khaimah, the US$5.1 billion development represents one of the most ambitious luxury hospitality projects in the Middle East and will introduce a new benchmark for integrated resort experiences in the region.

Developed by Wynn Design & Development in partnership with Marjan LLC, Wynn Al Marjan Island has been envisioned as an opulent and entertaining beachside destination for discerning global travelers. The resort occupies a picturesque island of more than 60 hectares that curves gracefully into the Arabian Gulf, offering a striking sense of arrival and seclusion.

Rising 70 stories and reaching a height of 352 meters, the resort’s shimmering tower will feature 1,530 elegantly appointed accommodations, all offering panoramic water views. This includes 313 suites within Enclave, a boutique hotel occupying the tower’s uppermost floors and designed to deliver an elevated, highly personalized guest experience.

Amenities at Wynn Al Marjan Island will include 22 restaurants and lounges, a vibrant beach club, a state-of-the-art theatre, a five-star spa with salon and fitness facilities, a luxury shopping parterre, multiple swimming and wading pools, a 420-metre stretch of white-sand beach, a 98-berth deep-water marina, and Coral Court, a purpose-built events and celebrations center designed to host weddings, social occasions, and large-scale gatherings.

“We are delighted to welcome Wynn Al Marjan Island into our Legend Collection, joining a portfolio of iconic properties that set global standards for luxury and experiential travel,” said Saurabh Rai, Executive Vice President of South Asia, Middle East, and Africa at Preferred Hotels & Resorts. “This landmark development not only exemplifies the ambition and innovation that defines the Legend Collection but also reflects our expanding global partnership with Wynn Resorts, whose legendary properties in Las Vegas, Macau, and Boston are already part of our family. Together, we are setting bold new benchmarks for ultra-luxury hospitality in the UAE and beyond.”

“From the outset, Wynn Al Marjan Island has been designed to deliver a truly singular guest experience, one that blends a strong sense of place with the scale, creativity, and service for which Wynn is known,” said Max Tappeiner, President, Wynn Al Marjan Island. “Our inclusion in Preferred Hotels & Resorts’ Legend Collection reflects a shared focus on distinctive, experience-led hospitality as we look ahead to our Spring 2027 opening.”

The ultimate portfolio of exceptional properties in the world’s most remarkable destinations, the Preferred Hotels & Resorts Legend Collection is globally sophisticated and culturally refined with singular properties that feature exquisite accommodations, stellar and intuitive personal service, renowned dining, and exceptional spas – setting the stage for the most unforgettable experiences.

Upon opening, guests of Wynn Al Marjan Island will be eligible to enroll in I Prefer Hotel Rewards, Preferred Hotels & Resorts’ points-based loyalty program with more than 6 million members worldwide. Complimentary to join, I Prefer members earn points redeemable for cash-value Reward Certificates, elite status, and additional benefits at over 650 participating properties across the globe. Travelers seeking exceptional independent hotel experiences are invited to register at www.IPrefer.com/enroll.

For more information about Wynn Al Marjan Island and Preferred Hotels & Resorts’ Legend Collection, visit www.PreferredHotels.com.

About Preferred Hotels & Resorts
Preferred Hotels & Resorts is the world’s largest independent hotel brand, representing more than 625 distinctive hotels, resorts, residences, and unique hotel groups across 80 countries. Through its curated global collections, Preferred Hotels & Resorts connects discerning travellers to the singular luxury hospitality experience that meets their life and style preferences for each occasion. Every property within the portfolio maintains the high-quality standards and unparalleled service levels required by the Preferred Hotels & Resorts Integrated Quality Assurance Programme. The I Prefer™ Hotel Rewards programme, Preferred Residences℠, Preferred Pride℠, and Preferred Golf™ offer valuable benefits for travellers seeking a unique experience. For more information, visit PreferredHotels.com.

About I Prefer Hotel Rewards
Launched in August 2013, the I Prefer Hotel Rewards program from Preferred Travel Group – the parent company that operates hotel brands Preferred Hotels & Resorts, Beyond Green, Historic Hotels of America, and Historic Hotels Worldwide – extends points, status, and other complimentary benefits to members upon eligible stays at over 650 participating hotels and resorts worldwide. In addition to earning points for eligible room nights, members receive additional benefits based on their tier status. The I Prefer programme also offers a free mobile app, available on Apple and Android devices, which allows members to search and book hotel stays, and easily redeem Reward Certificates. With more than 6 million travellers currently enrolled in membership, I Prefer is complimentary to join. To learn more and to enrol in the program, please visit IPrefer.com/enroll.

About Wynn Resorts
Wynn Resorts, Limited, is traded on the Nasdaq Global Select Market under the ticker symbol WYNN and is part of the S&P 500 Index. Wynn Resorts owns and operates Wynn Las Vegas (wynnlasvegas.com) and operates Encore Boston Harbor (encorebostonharbor.com). It is the majority shareholder of Wynn Macau, Limited, which is listed on the HKSE (1128.HK), and includes Wynn Macau (wynnmacau.com) and Wynn Palace in Cotai (wynnpalace.com). The Company, along with its equity partners, is constructing an Integrated Resort in Ras Al Khaimah, United Arab Emirates, set to open in early 2027.
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
MindBio Appoints National Drug Policy & Mining Industry Expert to Lead South American Mining Industry Commercialisation stocknewsapi
MBQIF
Vancouver, British Columbia – TheNewswire - February 24, 2026 – MindBio Therapeutics Corp. (CSE: MBIO | Frankfurt: WF6 | OTCQB: MBQIF) (“MindBio” or the “Company”), a biotechnology innovator commercializing AI-powered voice analytics for real-time drug and alcohol impairment detection, today announced the appointment of Felipe Leyton — one of South America’s most influential drug and alcohol policy architects and a recognized mining industry safety authority — to lead commercialization across the South American mining sector.

Mr. Leyton was part of the technical and operational implementation of Chile’s landmark Zero Tolerance framework for alcohol-impaired driving and will now spearhead deployment of MindBio’s Voice-Initiated AI Drug & Alcohol Screening Platform into one of the world’s largest and highest-risk industrial markets.

This appointment represents a significant inflection point as MindBio transitions from advanced development to commercial field deployment.

(0.b)National Policy Architect with Deep Mining Industry Access

Felipe Leyton is widely regarded as a leading authority in alcohol and drug public policy, mining industry safety, regulatory implementation, and evidence-based prevention strategy in South America.

He previously served as:

Head of Chile’s National Alcohol Prevention Unit 

Head of National Prevention Programs 

He led for several years the technical and operational implementation of Chile’s Zero Tolerance alcohol law currently in force, significantly expanding nationwide roadside control coverage and strengthening enforcement capacity. He also contributed to the design and implementation architecture of Chile’s national roadside drug testing program, launched in 2019.

Mr. Leyton is currently a Partner at TConsulting, (https://tconsulting.cl/) advising major Chilean mining operators, government ministries, and international organizations on:

Drug and alcohol prevention strategy 

Regulatory compliance 

Workplace health promotion 

Industrial safety culture transformation 

His combination of national regulatory leadership and direct mining industry engagement positions MindBio for accelerated enterprise adoption.

(0.c)Strategic Commercial Mandate

Under his engagement with MindBio, Mr. Leyton will:

Develop and finalize mining-specific testing protocols with MindBio’s engineering team 

Expand clinical validation and refine AI prediction models 

Strengthen multi-substance detection capability including cocaine, benzodiazepines, amphetamines, cannabis, hallucinogens, and alcohol 

Develop scalable enterprise licensing frameworks for mining operators 

Oversee phased deployment into active mining environments 

His mandate directly targets commercial revenue generation within the South American mining sector.

(0.d)Edge AI Hardware Kiosk Platform Ready for Field Deployment – Q2 2026

MindBio is near completion of the prototype design of its integrated Edge AI hardware-software kiosk system, purpose-built for industrial environments.

On-site field testing at mining operations is scheduled to commence in Q2 2026, marking a major commercial milestone.

The platform delivers:

Rapid, non-invasive screening 

Real-time AI-driven impairment prediction using Voice 

Scalable on-site deployment 

Reduced operational friction compared to traditional biological testing methods 

(0.e)Large and Urgent Safety Market Opportunity

Substance use remains a significant occupational safety risk in heavy industry.

In Chile alone:

Alcohol consumption among mining workers exceeds 75% 

Approximately 40% are classified as problem drinkers 

Approximately 9% report drug use 

The mining workforce exceeds 200,000 individuals 

(ACHS, 2012; SENDA, 2024)

Globally, an estimated 20–25% of occupational accidents are directly or indirectly linked to substance use (International Labour Organization, 1996; 2022; Gomez et al., 2002).

These data underscore a substantial global opportunity for scalable, real-time impairment detection technologies in safety-critical industries.

Justin Hanka, CEO of MindBio, stated:

“Mr Leyton brings exceptional credibility, regulatory authority, and direct access to the mining industry. He helped design and implement Chile’s Zero Tolerance alcohol framework at a national level, and he now leads the commercialization in a world-first AI voice-based impairment detection platform for mining.

This marks a transition from technology development to structured commercial deployment. We believe this positions MindBio at the forefront of next-generation industrial safety solutions and Voice initiated health diagnostic technologies.”

MindBio continues to position itself at the intersection of biotechnology, artificial intelligence, and medical diagnostics — building scalable, non-invasive solutions designed to improve safety outcomes, reduce liability exposure, and modernize impairment detection across global high-risk industries.

   For further information, please contact:

  Justin Hanka, Chief Executive Officer

+61 433140886

[email protected]

www.mindbiotherapeutics.com

  About MindBio Therapeutics Corp.

MindBio is a biotechnology company that is commercialising AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The Company is now collecting data that will allow its prediction tool to work on other types of intoxication for use in consumer and enterprise environments.

Cautionary Note Concerning Forward-Looking Statements:

The press release contains “forward-looking statements” within the meaning of applicable securities laws, including but not limited to, the Company’s ability to complete the Offering and option grants on the terms announced, and the development of its enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “budget,” “believe,” “project,” “estimate,” “expect,” “scheduled,” “forecast,” “strategy,” “future,” “likely,” “may,” “to be,” “could,” “would,” “should,” “will” and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and conditional. Forward-looking statements are based on assumptions as of the date they are provided. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Additionally, there are known and unknown risk factors that could cause the Company’s actual results and financial conditions to differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important risk factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements, include among others: the risk that the Company may not be able to raise the gross proceeds of the Offering; the failure to obtain the final regulatory approval; and technical challenges in the development or deployment of its enterprise platform; general economic, market and business conditions in Canada and Australia; market volatility; and unforeseen delays in timelines for any of the transactions or events described in this press release.  All forward-looking information is qualified in its entirety by this cautionary statement.

The Company disclaims any obligation to revise or update any such forward-looking statement or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of the information in this press release.

 
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Fabrice David as Independent Director stocknewsapi
RNWF
Independent Scientific Leader Strengthens Governance as American Fusion Advances Texatron™ Platform, Patent Expansion, and SEC Registration Filing

Southlake, Texas,  February 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Renewal Fuels, Inc. (OTC: RNWF) (“RNWF”, “American Fusion” or the “Company”), today announced the appointment of Fabrice David as an Independent Director of the Company, effective February 23, 2026.

Mr. David is an independent scientific researcher, inventor, and strategic advisor with more than two decades of experience spanning fusion-related energy science, advanced nuclear phenomena, propulsion systems, and applied biotechnology. He has authored or co-authored more than 130 scientific publications and holds numerous patents across advanced energy systems, nuclear science, and experimental physics.

Throughout his career, Mr. David has maintained sustained engagement in fusion-adjacent research, including participation in leading international conferences focused on fusion energy, low-energy nuclear reactions, plasma-based systems, and advanced energy conversion. His work reflects a long-term focus on non-conventional fusion pathways, experimental validation, and intellectual property development, aligning closely with American Fusion’s strategic direction.

Mr. David previously served as a Partner and Board Member of DEUO Dynamics in the United Kingdom, where he contributed to governance and strategic oversight of advanced fusion and cold-fusion research initiatives. In that role, he supported research evaluation, intellectual property development, international scientific collaboration, and commercialization pathways — experience directly relevant to fusion enterprises navigating the transition from advanced research to infrastructure-scale deployment.

In addition to his work in fusion-adjacent science, Mr. David founded and operated a photovoltaic solar distribution business, providing firsthand exposure to clean-energy commercialization, deployment logistics, and market adoption dynamics. His background spans both frontier research and applied energy markets, offering a balanced perspective on long-horizon innovation and practical energy infrastructure development.

As an Independent Director, Mr. David will provide scientific and technical oversight, insight into intellectual property strategy, and independent judgment supporting disciplined governance as the Company advances its Texatron™ aneutronic fusion platform toward commercial deployment.

“Fabrice brings deep scientific credibility and long-standing engagement in fusion-related research. His experience across experimental validation, intellectual property development, and international scientific collaboration strengthens our Board as we continue building a scalable fusion energy platform.”

Brent Nelson, CEO of Kepler Fusion Technologies “Independent scientific oversight is critical as we advance toward commercialization. Fabrice’s background reflects decades of disciplined research and intellectual rigor across fusion-adjacent systems and advanced energy technologies. His perspective supports our commitment to long-term value creation, strong governance, and responsible innovation.”

Richard Hawkins, Chairman and CEO of Renewal Fuels, Inc. The Company continues to advance additional patent filings supporting the Texatron™ platform. In parallel, the Company remains focused on its regulatory initiatives, including preparation of its Form 10 registration statement under the Securities Exchange Act of 1934, which is now substantially complete. The Company is in the process of obtaining the required EDGAR access codes in order to file the Form 10 with the Securities and Exchange Commission and expects to file next week. The PCAOB audit for fiscal years 2024 and 2025 is nearing completion, with only one remaining audit item outstanding prior to finalization. The Company is continuing to progress its pending corporate action with FINRA related to its transition to American Fusion.

For additional background on Mr. David’s scientific publications and research activity, please visit his ResearchGate profile at: https://www.researchgate.net/profile/Fabrice-David-3

For more information about Kepler Fusion Technologies and its Texatron™ platform, please visit: www.keplerfusion.com and americanfusionenergy.com

About Renewal Fuels, Inc. and American Fusion

Renewal Fuels, Inc. (OTC: RNWF) is an advanced energy platform company focused on the development and commercialization of fusion energy technologies through its wholly owned subsidiary, Kepler Fusion Technologies. Following its previously announced merger with Kepler, the Company is operating under the American Fusion brand and has filed a corporate action with FINRA to change its legal name to American Fusion Inc. The Company’s strategy is centered on building a scalable, infrastructure-grade fusion energy platform supported by proprietary technology, disciplined intellectual property development, and long-term commercial deployment objectives.

About Kepler Fusion Technologies

Kepler Fusion Technologies is an advanced energy technology company developing the Texatron™ aneutronic fusion platform. Kepler’s technology is designed to support modular, infrastructure-grade deployment for industrial, commercial, and grid-constrained applications. The Company’s development strategy emphasizes system-level engineering, disciplined intellectual property protection, and scalable architectures intended to support long-term commercial operation. Kepler Fusion Technologies operates as a wholly owned subsidiary of Renewal Fuels, Inc. (OTC: RNWF).

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the Company’s plans, objectives, expectations, and intentions, such as statements relating to technology development and commercialization, patent filings, regulatory initiatives, SEC registration, audit completion, exchange uplisting, and future business operations. Words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “potential,” “should,” and “will” identify forward-looking statements. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including risks related to technology development, intellectual property protection, regulatory approvals, capital availability, audit and SEC reporting timelines, exchange requirements, litigation matters, and general market and economic conditions. This release is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. The Company undertakes no obligation to update forward-looking statements except as required by law.

Source: Renewal Fuels, Inc.

The latest news and updates relating to $RNWF are available in the company’s newsroom at: https://tinyurl.com/rnwfnewsroom

PMW on Newsramp: https://newsramp.com/newswire/prism
2026-02-24 13:11 2mo ago
2026-02-24 08:05 2mo ago
Buyout Chatter Lifts PYPL Stock Following Executive Shakeup stocknewsapi
PYPL
PayPal shares jumped 5.8% on buyout speculation after a CEO change, as investors eye a potential premium deal despite recent earnings misses.
2026-02-24 13:11 2mo ago
2026-02-24 08:06 2mo ago
American Tungsten Reports Drilling Results from IMA Project, Expands Tungsten-Silver Mineralization stocknewsapi
TUNGF
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2026) - American Tungsten Corp. (CSE: TUNG) (OTCQB: TUNGF) (FSE: RK90) ("American Tungsten" or the "Company") is pleased to report additional tungsten-silver assay results from its on-going underground drilling program at the IMA Mine, Lemhi County, Idaho. Drilling to date has expanded the extent of the No. 5 - No.7 vein system over 300 feet up-dip of the D-level and over 350 feet along strike.

Drill Result Highlights:

14.2 ft grading 0.67% WO3 and 1.15 oz/t Ag in hole AT25-06; and17 ft grading 1.28% WO3 and 3.53 oz/t Ag in hole AT25-07"These results continue to demonstrate that the IMA Mine hosts a robust and laterally extensive tungsten-silver system," said Ali Haji, CEO of American Tungsten Corp. "The consistency of mineralization we are defining strengthens our confidence in the project's scale and supports our path toward a modern resource and the potential restart of mining operations. With each hole, the opportunity at IMA becomes clearer."

Drillholes AT26-06 and AT26-07 were drilled to expand limits of mineralization up-dip from drillhole AT25-01, as reported February 10, 2026. Both drillholes intersected the No. 5 and No. 7 veins, which have now been delineated over 300 feet up-dip from the D-level. Drillhole AT26-07 intersected the No 7 vein from 273-298 ft, but assay results for this interval of hole have not yet been received.

Drillhole AT26-05 was drilled south-southwest oblique to the vein strike direction and intersected multiple broad zones of sheeted quartz veining containing hubnerite-tetrahedrite mineralization including 20.6 ft grading 0.25% WO3 and 11 ft grading 0.23% WO3. These intercepts establish continuity of mineralization over 350 south of intercepts in AT25-01. Additional drilling from locations 400 ft to the north is designed to further test the vein system up-dip and along strike.

New drillhole results are reported in Table 1 below, and assays for additional completed drillholes are pending.

Table 1: Summary Drillhole Assay Results From IMA Tungsten Project

Hole IDAzimuthDipHole LengthFrom (ft)To (ft)Length (ft)WO3 %MoS2%Ag oz/tCu %Pb %Zn %AT26-05150353896363.50.55.110.000.080.010.050.02and178.419920.60.250.090.860.060.140.02including185195100.360.101.330.050.200.03and21421950.590.081.330.060.150.02and238.52412.50.310.141.150.080.130.03and251262110.230.040.780.020.090.01including25125540.500.031.580.030.130.02AT26-06253702548599.814.80.310.072.270.040.160.01including97.299.82.60.830.151.700.030.210.02and134148.414.40.260.012.720.020.010.02including144148.44.40.380.000.040.010.010.01and182.819714.20.670.131.150.090.130.05including185.11937.90.750.110.930.010.100.01and205.12104.90.210.040.990.030.080.01and221.62264.40.250.100.460.010.080.01AT26-076560476.51525101.100.010.690.050.090.04and115118.83.80.470.022.280.180.190.20and155172171.280.063.530.270.340.09and26727250.240.040.690.220.090.08assays pending272476.5 
1) Intercepts not true width; true width of vein intercepts are estimated to be 90% of composite length for AT26-06 , 50% of composite length for AT26-05 and 60% of composite length for AT26-07
2) WO3 and MoS2 % values are calculated from ppm analyses based on stoichiometry factors of 1.2611 and 1.668, silver is reported in troy ounces per ton
3) Composites are generated using a 0.1% WO3 cut-off grade or 0.5oz/t Ag grade and may include internal waste below cut-off grade.

American Tungsten has completed 11 drillholes on the D level and three drillholes on the Zero level totaling approximately 5000 feet. Drilling on the zero level is being conducted in a series of upward inclined fan holes from new drill stations in the footwall of the No.5 and No.7 vein systems. Mineralization in the principal veins consists of variable assemblages of hubnerite, scheelite, tetrahedrite, galena, sphalerite, and chalcopyrite, plus fluorite and rhodochrosite. Additional mineralization is associated with minor veins and stockworks within intervening metasedimentary host rocks.

Figure 1: Vertical Section Looking North showing significant intercepts and vein system interpretation, 100 ft view corridor.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11701/285068_0065bcaf5473cb6d_001full.jpg

Figure 2: Plan map of the D-level showing completed and planned drillholes. Drillhole AT25-04 omitted for clarity.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11701/285068_0065bcaf5473cb6d_002full.jpg

Phase 1 Drill Program

Drilling operations are ongoing from the second D level drill station and excavation of the drift to the third drill station is underway. Currently, at least six additional holes totaling approximately 2800 feet are planned from on the D level and more holes may be added to the program based on results. Drilling and mine rehabilitation operations are also being conducted on the Zero level. Drilling on the zero level will include up to 20 holes totaling approximately 10,000 feet from three locations.

About the IMA Mine

The IMA Mine is a past producing underground tungsten mine situated on 22 patented claims located in East Central Idaho. Between 1945 and 1957, the property produced approximately 199,449 MTUs of WO3 and was subsequently explored for molybdenum and tungsten by various operators between 1960-2010. American Tungsten Corp is currently conducting an exploration drill program and assessing potential for re-start of underground tungsten mining operations at the IMA Mine.

Sampling Methodology

Drillholes were completed using a Hagby 1000 drill rig with NQ sized rods. Drill core was transferred to American Tungsten geologists under chain of custody and stored in a secure facility. Drill core was logged for lithology, alteration, mineralization, and structure prior to sampling. Sample number tags were affixed to core boxes and core marked for sawing. Core was sawn in half, with one half submitted for analysis and the remaining half retained for reference. Samples were collected at approximate 5 foot intervals in wall rock and shorter intervals within vein mineralization, with sample lengths adjusted to geological boundaries where appropriate. Samples were submitted for assay to ALS Global in Twin Falls, Idaho.

QA/QC and Sample Analysis

American Tungsten Corp's Quality Assurance and Quality Control QA/QC program applies industry standard best practices to ensure data quality and integrity for the IMA Mine project, including maintaining chain of custody, secure sample transport and storage, adherence to data collection protocols and inclusion of certified reference, blank and duplicate quality assurance samples in laboratory submissions.

Samples were submitted to ALS Global laboratory in Twin Falls, Idaho, for preparation. Samples were crushed to 70% passing 2 mm screen, rotary splitting 250g and pulverized to 85% passing a 75 μm screen. Samples were analyzed by ALS Minerals in the Vancouver, BC, Canada. Samples were analyzed by four acid digest with ICP-MS finish. Samples exceeding 200 ppm W were analyzed by XRF with lithium borate fusion preparation. Samples exceeding 50ppm Ag were analyzed by fire assay with gravimetric finish.

Qualified Person

Technical information in this news release has been prepared in accordance with Canadian regulatory requirements set out in National Instrument 43-101 - Standards of Disclosure for Mineral Projects ("NI-43-101"). Austin Zinsser, P.G., SME-RM, Vice President, Exploration for the Company, and a Qualified Person as defined by NI-43-101, has reviewed and approved the scientific and technical information in this news release.

About American Tungsten Corp.

American Tungsten Corp. is a Canadian exploration company focused on high-potential tungsten and magnetite assets in North America. The Company is advancing the IMA Mine Project in Idaho to commercial production, addressing critical metal scarcity in North America. The Company's IMA Mine Project is a historic and high-quality underground tungsten past-producing property on private-patented land well above the water table with significant infrastructure. The Company holds an exclusive option to acquire full ownership (subject to a 2% royalty) and has expanded its land position with 113 additional federal claims covering nearly 2,000 acres.

For further updates, visit www.americantungstencorp.com or investor relations, Joanna Longo at [email protected].

Social media links:
LinkedIn: https://www.linkedin.com/company/americantungstencorp/
X: https://x.com/amtungsten
Facebook: https://www.facebook.com/americantungstencorp/
Instagram: https://www.instagram.com/americantungstencorp/
YouTube: https://www.youtube.com/@americantungstencorp

CSE: TUNG
OTCQB: TUNGF
FSE: RK90

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved the contents of this press release.

This news release includes "forward-looking information" that is subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company. Forward-looking statements may include but are not limited to, statements relating to anticipated results of future drilling, recommencement of mining or production, pending analyses, future work plans and all the risks and uncertainties normally incident to such events. Investors are cautioned that any such statements are not guarantees of future events and that actual events or developments may differ materially from those projected in the forward-looking statements. Such forward-looking statements represent management's best judgment based on information currently available. No securities regulatory authority has either approved or disapproved of the contents of this news release. The Company undertake no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.

Statements concerning historical mineral resources, production, and exploration results on the property have been obtained through both public and private sources, and are believed to be substantially factual and relevant in that they demonstrate the tenor of exploration targets on the property. Historical resource estimates pre-date the implementation of NI 43-101 and do not use categories stipulated by CIM. Prior operators assigned confidence categories which differ from those stipulated by CIM, as they may not have demonstrated economic viability. The estimates should not be relied upon until they have been verified. Neither American Tungsten Corp., or its Qualified Person, has done sufficient work to classify the historical estimates as current mineral resources or to verify historical information regarding past production, sampling or drilling. American Tungsten Corp. is not treating the historical estimates as current mineral resources or mineral reserves. Exploration Targets discussed are conceptual in nature; it is uncertain whether a mineral resource will be delineated based on potential exploration.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/285068

Source: American Tungsten Corp.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us
2026-02-24 13:11 2mo ago
2026-02-24 08:06 2mo ago
S&P 500 expected to start flat as new Trump tariffs begin stocknewsapi
IVV SPLG SPXL SPY SSO UPRO VOO
A moderately positive start for US stocks is expected on Tuesday, after Donald Trump's new 10% global tariff kicked in overnight. 

Nasdaq futures were up 0.2%, while those for the Dow Jones were pointing to a 0.1% gain, while S&P 500 futures were flat.

The previous day, the Dow fell roughly 820 points or 1.7% to 48,804, while the Nasdaq dropped 1.1% to 22,627 and the S&P closed down 1% at 6,837 points.

Prominent among fallers were American Express, Mastercard, Visa, DoorDash and Uber, dropping between 7% and 4% as the AI fear trade spilled over into delivery and payment stocks.

Analysts said investors were reacting to a research report from Citrini Research last week, entitled "The 2028 Global Intelligence Crisis", which outlined a hypothetical scenario in which AI adoption drives the US unemployment rate into double digits by mid 2028.

AI disruption fears also hit the likes of Workday, Datadog and IBM, then spread to the US private capital groups who have been buyers of these software stocks, such as Ares, KKR and Blackstone, as concerns grew about exposure to the software sector and last week’s announcement from Blue Owl that it was halting redemptions and selling more than $1 billion in loans to manage liquidity pressures.

European and Asian stocks were mixed in earlier trading on Tuesday, with fallers including banks and financials as investors read across to the declines in the US.  

Trump’s new tariffs came into effect from midnight Eastern Time, but his plans for a steeper 15% tariff were held back for now.

According to reports, the move follows a backlash from several US partners, including the EU and the UK, over the higher proposed rate, while other reports suggested the Trump administration was preparing new Section 232 national security investigations into industries such as batteries, telecom equipment and industrial chemicals.

The White House signalled that the 15% tariff has not been dropped altogether. “It is being worked on and will come later,” an official said, without giving a timetable.

AMD was a big mover in pre-market trading on Tuesday, up 12% after Meta struck a multi-year partnership to build vast new AI data centres, deploying up to 6GW of advanced graphics processors.

Home Depot shares climbed 2.3% after the retailer posted fourth-quarter results that just beat analyst forecasts, offering some reassurance that the business remains stable even as its core customers pull back on spending.

Other earnings include Workday, HPQ, Lucid, Cava and AMC, with data including US consumer confidence and Trump's State of the Union address in the evening. 
2026-02-24 13:11 2mo ago
2026-02-24 08:07 2mo ago
Safe Pro to Demonstrate Integrated AI Capabilities on General Dynamics Mission Systems' GeoSuite at U.S. Army TiC 2.0 Event at Fort Hood, Texas stocknewsapi
SPAI
AVENTURA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (Nasdaq: SPAI) (Safe Pro or the Company), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, today announced that it will be demonstrating its AI-powered Navigation, Observation & Detection Engine (NODE) threat detection capability integrated into General Dynamics Mission Systems’ GeoSuite mission planning and execution toolkit at the upcoming Army Transforming in Contact (TiC) 2.0 Autonomous Breach event being held at Fort Hood, Texas.

The U.S. Army’s Transforming in Contact (TiC) 2.0 Autonomous Breach event is the latest element of its $1 billion initiative (through FY27) to sponsor and fund the rapid equipping and testing of advanced technologies including drones, electronic warfare (EW), and mission planning technologies, directly with soldiers. During the TiC 2.0 Autonomous Breach event, participating industry teams will integrate and demonstrate their technologies alongside soldiers from the 1st Cavalry Division and the 36th Engineer Brigade, III Corps., as they seek to adapt to modern, high-intensity battlefield conditions. At the TiC 2.0 event, Safe Pro will be showcasing its NODE AI processing system integrated with General Dynamics Mission Systems’ GeoSuite tactical situational awareness platform. Through participation in TiC 2.0, Safe Pro seeks to further establish itself as a provider of critical decision support data and tools for a wide array of missions including combined arms breaching, maneuver operations, force protection and global humanitarian demining.

“As an Army sponsored vendor participating in TiC 2.0, we have a valuable opportunity to directly showcase NODE’s unique ability to support Army units by providing our real-time explosive threat detection and mapping capabilities for soldiers on the ground. We are especially excited to integrate our AI-powered detection data into the widely fielded GeoSuite platform, building a novel solution that can rapidly deliver greatly enhanced operational situational awareness to the teams taking part in this critical technology event,” said Dan Erdberg, Chairman and CEO of Safe Pro Group Inc.

GeoSuite empowers tactical leaders to efficiently analyze, plan, rehearse, execute and review operations utilizing an intuitive map-centric interface including unique multimedia tools, advanced planning capabilities and visualizations specifically focused on the operational environment. With a focus on rapid dissemination and sharing of critical information, GeoSuite delivers real-time actionable intelligence and situational data in Disconnected, Intermittent, and Limited (DIL) environments.

NODE is a proprietary edge-based, turnkey, rapid field-deployable system for next-gen situational awareness built on the Company’s patented Safe Pro Object Threat Detection (SPOTD) platform. The system can provide 2D and 3D interactive mapping and hazard detection on the edge with real-time threat detection capabilities allowing field personnel and commanders to make more informed decisions in communication-restricted or denied environments.

Safe Pro’s SPOTD AI platform analyzes imagery and video from virtually any drone to automatically detect and classify explosive threats and other objects of interest. The platform converts raw video into high-resolution 2D/3D geospatial models that can be rapidly shared to support operational decision-making in defense, security, and humanitarian missions. SPOTD is capable of identifying more than 150 types of landmines and UXO, enabling scalable situational awareness across large, high-risk areas. SPOTD has been deployed in active operational environments in Ukraine for nearly three years and is supported by a growing proprietary dataset comprising over 2.4 million analyzed images, more than 44,000 identified threats, and coverage of approximately 29,300 acres. Through recent collaboration in the Middle East and ongoing work in the Philippines, the Company believes this real-world validation and data advantage meaningfully differentiates its platform and positions Safe Pro to address expanding global demand for AI-enabled threat detection and post-conflict recovery solutions.

For more information about Safe Pro’s real-world landmine and UXO detections, visit: https://safeproai.com/landmine-detections/. Information about Safe Pro Group, its subsidiaries, and technologies, please visit https://safeprogroup.com and connect with us on LinkedIn, Facebook, and X.

About Safe Pro Group Inc.
Safe Pro Group Inc. (NASDAQ: SPAI) is a mission-driven technology company delivering AI-enabled security and defense solutions. Through cutting-edge platforms like SPOTD, Safe Pro provides advanced situational awareness tools for defense, humanitarian, and homeland security applications globally. It is a leading provider of artificial intelligence (AI) solutions specializing in drone imagery processing, leveraging commercially available “off-the-shelf” drones with its proprietary machine learning and computer vision technology to enable rapid identification of explosives threats, providing a much safer and more efficient alternative to traditional human-based analysis methods. Built on a cloud-based ecosystem and powered by Amazon Web Services (AWS), Safe Pro Group’s scalable platform is targeting multiple markets that include commercial, government, law enforcement and humanitarian sectors where its Safe Pro AI software, Safe-Pro USA protective gear and Airborne Response drone-based services can work in synergy to deliver safety and operational efficiency. For more information on Safe Pro Group Inc., please visit https://safeprogroup.com/.

Forward-Looking Statements
Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements relate to future events, future expectations, plans and prospects. Forward-looking statements in this press release include, without limitation, Safe Pro’s ability to support U.S. Army operations, its ability to integrate its technology with third party systems and the acceptance of its solutions by potential government, military and humanitarian organizations. Although Safe Pro Group believes the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Safe Pro Group has attempted to identify forward-looking statements by terminology including ''believes,'' ''estimates,'' ''anticipates,'' ''expects,'' ''plans,'' ''projects,'' ''intends,'' ''potential,'' ''may,'' ''could,'' ''might,'' ''will,'' ''should,'' ''approximately'' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including market and other conditions. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth under Item 1A. in the Company’s most recently filed Form 10-K and updated from time to time in the Company’s Form 10-Q filings and in other filings with the Securities and Exchange Commission (the “SEC”), copies of which may be obtained from the SEC’s website at www.sec.gov. Any forward-looking statements contained in this press release speak only as of its date. Safe Pro Group undertakes no obligation to update any forward-looking statements contained in this press release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events, except as required by law.

Media Relations for Safe Pro Group Inc.:

[email protected]

Investor Contact:

Ankit Hira, Managing Director
Solebury Strategic Communications for Safe Pro Group Inc.
[email protected]
2026-02-24 13:11 2mo ago
2026-02-24 08:07 2mo ago
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market stocknewsapi
NXL
150-Patient, Triple-Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission for Drug-Free Insomnia Treatment

Builds on Prior Peer-Reviewed Clinical Data and International Regulatory Approvals

HOUSTON, TX, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical research organization engaged to oversee trial execution, regulatory preparation, and patient recruitment.

The randomized, triple-blinded, sham-controlled study is designed to enroll a minimum of 150 participants across the United States. Structured as a fully decentralized trial, participants are expected to complete treatments and assessments remotely within Nexalin’s recently launched NeuroCare virtual clinic and its advanced Electronic Data Capture (EDC) system. The NeuroCare virtual clinic is designed to eliminate traditional site visit requirements, while expanding access to a broader patient population.

The pivotal study is designed to support the planned de novo insomnia submission to the U.S. Food and Drug Administration and represents a key milestone in the execution of Nexalin’s global strategy to expand its DIFS™ platform into high-prevalence neuropsychiatric indications.

The pivotal study to support Nexalin’s planned FDA submission builds on Nexalin’s previously reported and published clinical results in chronic insomnia, including a 120-participant randomized, double-blind, placebo-controlled, multicenter study published in the Journal of Psychiatric Research. In that study, Nexalin reported clinically meaningful and statistically significant improvements across key sleep parameters compared to placebo, with no significant adverse effects reported. Nexalin’s Gen-2 15 mA device has also received regulatory approvals internationally for insomnia and related indications.

Insomnia affects approximately 30 million adults in the United States, with many patients reporting dissatisfaction with existing treatment options due to concerns regarding dependency, tolerability, or long-term use. The global insomnia therapeutics market represents a multi-billion-dollar annual opportunity and continues to grow as awareness and diagnosis increase.

HALO™ Clarity leverages Nexalin’s proprietary 15 mA DIFS™ technology, which is engineered to target deeper brain structures associated with sleep regulation and other mental health conditions. Unlike conventional transcranial stimulation approaches primarily targeting cortical regions, DIFS™ is engineered to modulate deeper neural circuits implicated in sleep architecture, offering a potential non-pharmacological treatment alternative.

Under the collaboration, Lindus Health is expected to provide comprehensive clinical research services, including protocol finalization, regulatory preparation and submission support, patient recruitment strategy, study management, data oversight, biostatistics, and medical writing.

The planned study will include adults aged 22 to 65 with moderate to severe insomnia, who are expected to be randomized to receive either active HALO™ Clarity therapy or sham treatment for four weeks, followed by a four-week follow-up period to evaluate durability of response.

“This planned pivotal trial marks an important milestone for Nexalin,” said Mark White, Chief Executive Officer of Nexalin Technology. “Insomnia is a large and underserved market where millions of patients are seeking drug-free treatment options. Advancing HALO™ Clarity toward a fully powered pivotal study designed to support our planned FDA submission reflects the maturity of our DIFS™ platform and our commitment to expanding its clinical reach. We believe successful execution of this study and continued advancement along the FDA pathway will position Nexalin to pursue regulatory clearance in a high-demand market, further validate the broader potential of our technology, and support our ongoing efforts to expand regulatory pathways across additional indications.”

“We are pleased to collaborate with Nexalin in the advancement of this important study,” said Michael Young, Co-CEO of Lindus Health. “Our team looks forward to supporting the execution of a rigorous, patient-centric trial designed to evaluate this novel approach to insomnia treatment.”

Nexalin continues to focus on strengthening the clinical and regulatory foundation of its DIFS™ platform as it advances toward potential commercialization across multiple neuropsychiatric indications.

About Nexalin Technology, Inc.

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin's products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, Oman and Israel. Additional information about the Company is available at: https://nexalin.com/.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events or Nexalin’s future financial performance. Any statements that refer to expectations, projections, or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements containing the words “believes,” “expects,” “anticipates,” “plans,” “intends,” “will,” “designed to,” “positioned to,” “potential,” “targeted,” “seeking,” or similar expressions) should be considered forward-looking statements. Such statements involve risks and uncertainties that could cause actual events or Nexalin’s actual results to differ materially from those indicated by the forward-looking statements. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release.

References to "FDA pivotal study," "FDA pivotal clinical trial," or similar terminology in this press release describe the Company’s intended purpose for the study and do not indicate FDA endorsement, sponsorship, approval, or oversight of the study design, protocol, or execution. No assurance can be given that the planned study will be initiated, enrolled, completed, or produce favorable results, or that any regulatory submission will result in FDA clearance or approval.

Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond the control of the Company. Such risks include, but are not limited to: uncertainties regarding the design, enrollment, execution, timing, and completion of clinical trials; the ability to obtain regulatory clearance or approval from the FDA or other regulatory bodies; the Company’s reliance on third-party collaborators, including Lindus Health; the sufficiency of clinical data to support regulatory submissions; the potential for adverse events or safety concerns; market acceptance of the Company’s products; competition from existing and new treatment alternatives; and the Company’s ability to secure adequate funding to complete its planned clinical and regulatory programs. Additional risks are set forth in the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and other filings with the Securities and Exchange Commission. Copies of such filings are available on the SEC’s website at www.sec.gov.

Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact:

Crescendo Communications, LLC
Tel: (212) 671-1020
Email: [email protected]
2026-02-24 13:11 2mo ago
2026-02-24 08:07 2mo ago
Western Midstream Partners, LP Common Units (WES) Discusses Fourth Quarter Performance, Cost-Cutting Initiatives, and Growth Strategy Progress Transcript stocknewsapi
WES
Western Midstream Partners, LP Common Units (WES) Discusses Fourth Quarter Performance, Cost-Cutting Initiatives, and Growth Strategy Progress Transcript
2026-02-24 13:11 2mo ago
2026-02-24 08:09 2mo ago
TNL Mediagene Leverages AWS's Kiro to Accelerate AI-Enabled Operational Advancements stocknewsapi
TNMG
Highlights TNL Mediagene's early enterprise adoption of Kiro, an agentic development environment built on Amazon Web Services (AWS) By adopting AWS Kiro, the Company enables its teams to use AI agents to assist with code development tasks, improving development efficiency and lowering the barrier to building and modernizing internal systems Demonstrates measurable improvements in workflow efficiency, project execution speed, and organizational alignment enabled through AI-supported operations Shows how a scalable AI-supported operational foundation contributes to stronger performance across the Company's diversified portfolio, including media brands and product innovation Positions the Company as a regional example of practical, enterprise-scale AI adoption , /PRNewswire/ -- TNL Mediagene (Nasdaq: TNMG) ("the Company"), a digital media and technology company operating multi-language news, lifestyle, and tech brands across Asia, and providing AI-driven advertising, data analytics, e-commerce, and marketing technology solutions, today announced the launch of a showcase initiative leveraging Amazon Web Services (AWS) Kiro, an agentic development environment, underscoring the Company's commitment to advancing AI-enabled operational transformation and accelerating modernization across its technology infrastructure.

AWS's Kiro is an agentic development environment that makes it easy for developers to ship real engineering work with the help of AI agents. By adopting AWS Kiro, the Company enables its teams to use AI agents to assist with code development tasks, improving development efficiency and lowering the barrier to building and modernizing internal systems.

The Company has invested significantly in AI-enabled development workflows using AWS to enhance efficiency, scalability, and operational resilience. Through the integration of structured processes and AI-assisted tools, the Company has achieved meaningful improvements in cross-team coordination, execution speed, and consistency across technology operations. These advancements strengthen the Company's ability to meet growing regional demand for digital content, advertising solutions, and data services.

The Company has also extended its AI-enabled workflows across its multi-brand media portfolio, which includes The News Lens, Business Insider Taiwan, INSIDE, Roomie, iCook, Cool3C, and Sports Vision. Improvements in project cycle time, team alignment, operational transparency, and organizational agility have enhanced the execution quality across the Company's diversified business lines.

As organizations across Asia accelerate their adoption of AI technologies, the Company's adoption of AWS's Kiro provides a real-world example of how media groups can meaningfully integrate AI into core operations. As highlighted in the Company's letter to shareholders and presentation released earlier this month, the Company has committed to operational transformation, its use of next-generation AI tools, and the measurable improvements enabled through these initiatives—further supporting the Company's position as an early mover in enterprise-scale AI adoption.

"Kiro, supported by AWS, has quickly become an important part of how we operate as a modern media and data organization. This initiative demonstrates our commitment to adopting advanced technologies that enhance efficiency and support long-term growth. We look forward to continuing to expand our AI-enabled operational capabilities," said Richard Lee, the Chief Technology Officer of TNL Mediagene.

The Company remains focused on leveraging AI, automation, and data intelligence to strengthen its operational foundation, enhance competitiveness, and support sustained growth in Asia's rapidly evolving digital economy. The Company's adoption of AWS's services reflects a long-term vision of innovation across its media, advertising, data, and product businesses while building a scalable foundation for the future.

In parallel with its AI-enabled transformation, the Company has continued to broaden its business portfolio, including expansion into its self-developed product offerings. iGood Price-Drop Radar is a self-developed product initiative developed as part of the Company's product expansion efforts. The app-based price drop notification system built by subsidiary iGood using Agile methodology, represents the Company's first self-developed LINE tool and demonstrates the Company's ability to create consumer-facing utilities that integrate naturally into everyday digital behavior in Taiwan.

About TNL Mediagene

Headquartered in Tokyo, TNL Mediagene was formed in May 2023 through the merger of Taiwan's The News Lens Co. and Japan's Mediagene Inc., two of the region's leading independent digital media groups. The company's operations span original and licensed media brands in Japanese, Chinese, and English, covering topics such as news, business, technology, science, food, sports, and lifestyle. It also offers AI-driven advertising services, marketing technology platforms, e-commerce, and innovative solutions tailored to the needs of advertising agencies. Known for its political neutrality, appeal to younger audiences, and high-quality content, TNL Mediagene has approximately 480 employees across Asia, with offices in Japan and Taiwan.

https://www.tnlmediagene.com/

Cautionary Statement Regarding Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to TNL Mediagene. Forward-looking statements generally relate to future events or TNL Mediagene's future financial or operating performance. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing," "target," "aim," "seek" or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements in this communication include, but are not limited to, statements about TNL Mediagene's future business plan and growth strategies and statements by TNL Mediagene's management. Any statements that refer to expectations, projections or other characterizations of future events or circumstances, including strategies or plans, are also forward-looking statements. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for TNL Mediagene to predict these events or how they may affect TNL Mediagene. In addition, risks and uncertainties are described in TNL Mediagene's filings with the Securities and Exchange Commission, including the risks and uncertainties set forth under the heading "Risk Factors" in TNL Mediagene's Annual Report on Form 20-F filed on April 30, 2025, as may be supplemented or amended by the TNL Mediagene's Reports of a Foreign Private Issuer on Form 6-K.  These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. TNL Mediagene cannot assure you that the forward-looking statements in this communication will prove to be accurate. There may be additional risks that TNL Mediagene presently does not know or that TNL Mediagene currently does not believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by TNL Mediagene, its directors, officers or employees or any other person. Except as required by applicable law, TNL Mediagene does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date of this communication. You should, therefore, not rely on these forward-looking statements as representing the views of TNL Mediagene as of any date subsequent to the date of this communication.

SOURCE TNL Mediagene
2026-02-24 13:11 2mo ago
2026-02-24 08:09 2mo ago
AmpliTech Group Announces Expiration of Previously Listed Warrants (NASDAQ: AMPGW) stocknewsapi
AMPGW
HAUPPAUGE, N.Y., February 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGR, AMPGZ) today announced that its previously listed warrants (Nasdaq: AMPGW) expired in accordance with their original terms at 5:00 p.m. Eastern Time on February 19, 2026. Trading in the warrants ceased at the close of market on February 18, 2026, after which the warrants were removed from listing on Nasdaq. The Company reports that prior to their expiration, there were a total of 1,371,428 warrants outstanding with each warrant granting the holder thereof the right to purchase one share of common stock at $7.00 per share.

Any AMPGW warrants that remained unexercised at expiration were voided and are of no further value. This expiration occurs automatically under the warrant agreement, does not require any action from warrant holders, and the Company no longer has to put these amount of shares in reserve. There is no impact on the Company’s common stock, Series A Right and Series B Right which will continue to trade on Nasdaq under the symbols AMPG, AMPGR, and AMPGZ.

About AmpliTech Group

AmpliTech Group, Inc., comprising five divisions, AmpliTech Inc., Specialty Microwave, Spectrum Semiconductors Materials, AmpliTech Group Microwave Design Center, and AmpliTech Group True G Speed Services, is a leading designer, developer, manufacturer, and distributor of cutting-edge radio frequency (RF) microwave components and ORAN 5G network solutions. Serving global markets including satellite communications, telecommunications (5G & IoT), space exploration, defense, and quantum computing, AmpliTech Group is committed to advancing technology and innovation. For more information, please visit www.amplitechgroup.com.

Safe Harbor Statement

This release contains statements that constitute forward-looking statements. These statements appear in several places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things, that this warrant expiration notice will have any effect on the current pricing of the AMPG publicly traded shares and Rights.  The words “may” “would” “will” “expect” “estimate” “anticipate” “believe” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward- looking statements because of various factors. Other risks are identified and described in more detail in the “Risk Factors” section of the Company’s filings with the SEC, which are available on our website and with the SEC at sec.gov. We undertake no obligation to update, and we do not have a policy of updating or revising these forward-looking statements, except as required by applicable law.

Contacts:

Corporate Social Media
X: @AmpliTechAMPG
Instagram: @AmpliTechAMPG
Facebook: AmpliTechInc
LinkedIn: AmpliTech Group Inc

Company Contact:
Jorge Flores
Tel: 631-521-7831
[email protected]

Investor Relations Contact:
Kirin Smith
PCG Advisory, Inc.
[email protected]

Source: AmpliTech Group, Inc.

The latest news and updates relating to $AMPG are available in the company’s newsroom at: https://tinyurl.com/ampgnewsroom

PMW on Newsramp: https://newsramp.com/newswire/prism
2026-02-24 13:11 2mo ago
2026-02-24 08:10 2mo ago
Ocumetics Announces Appointment of Raymond Marks to Board of Directors stocknewsapi
OTCFF
  Calgary, Alberta – TheNewswire - February 24, 2026 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, is pleased to announce that Raymond Marks has been appointed to its Board of Directors.

Raymond Marks was instrumental in the early fundraising efforts of the Company and participated in meetings that resulted in Ocumetics securing financing for its initial public listing by reverse takeover.

He has over 50 years of experience as an entrepreneur, owner, operator and manager across a variety of industries including the resources and industrial sectors. Throughout his career, Mr. Marks has worked with many such companies and has worked with growing companies to secure millions in financing for their strategic initiatives.

Mr. Marks previously co-founded Tudor Gold Corp. (TSXV:TUD) and served as executive Vice President, and a director of Tudor from February 2016 until October 2018. Mr. Marks later assisted in the formation of Hanstone Capital Corporation which later became Hanstone Gold Corp. where he served as President and Chief Executive Officer from October 2018 until October 2025. Mr. Marks helped secure over $16 million in financing for the two companies.

“We welcome Mr. Marks to the board of Ocumetics and look forward to benefiting from his capital markets experience and assistance with our next stage of fundraising,” says Dean Burns, President and CEO of Ocumetics.

About Ocumetics

Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients.  Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies.

Ocumetics is in the first-in-human early feasibility study phase of a game-changing technology for the ophthalmic industry.  Ocumetics has developed an intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses.  It is designed to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses.  

  FOR FURTHER INFORMATION, PLEASE CONTACT:

  Dave Burwell

Director, Investor Relations        

[email protected]

 (403) 410-7907       

                        Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation.  Forward-looking statements include, but are not limited to, statements with respect to the commencement, timing and scope of the research and development to be conducted by the Company.  Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include but are not limited to: operational matters, historical trends, current conditions and expected future developments, access to financing as well as other considerations that are believed to be appropriate in the circumstances.  There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.  The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
2026-02-24 12:11 2mo ago
2026-02-24 06:06 2mo ago
AVAX Price Prediction: Avalanche Targets $12-15 Recovery by April 2026 cryptonews
AVAX
Rebeca Moen Feb 24, 2026 12:06

Avalanche (AVAX) trades at $8.30 with RSI at 31.98 signaling oversold conditions. Technical analysis suggests potential 44-80% upside to $12-15 range within 4-6 weeks if key resistance breaks.

Avalanche (AVAX) is showing signs of a potential bottom formation at current levels around $8.30, with multiple technical indicators suggesting the cryptocurrency may be positioning for a significant recovery rally in the coming weeks.

AVAX Price Prediction Summary • Short-term target (1 week): $9.00-9.60
• Medium-term forecast (1 month): $12-15 range
• Bullish breakout level: $9.00 • Critical support: $7.86

What Crypto Analysts Are Saying About Avalanche Recent analyst coverage has been cautiously optimistic about Avalanche's prospects. Felix Pinkston noted on February 21, 2026: "Avalanche (AVAX) shows neutral RSI at 40.45 with analysts targeting $12-15 range within 4-6 weeks. Current price $9.17 faces key resistance at $9.60."

Zach Anderson provided additional insight on February 20, 2026, stating: "Avalanche (AVAX) shows signs of bottoming at $8.92 with neutral RSI. Technical analysis suggests potential 30-60% upside to $12-15 range within 4-6 weeks if key resistance breaks."

AInvest News analysis from February 20, 2026, reinforced this sentiment: "Avalanche (AVAX) is trading near $8.90–$9.26 with technical indicators suggesting potential for a recovery to $12–$15 if key resistance levels are breached."

AVAX Technical Analysis Breakdown The current technical setup for Avalanche presents a mixed but increasingly constructive picture. Trading at $8.30, AVAX sits just above the lower Bollinger Band at $8.28, indicating the cryptocurrency is testing significant support levels.

The RSI reading of 31.98 places Avalanche in neutral territory, though closer to oversold conditions, which historically has provided buying opportunities for the cryptocurrency. The MACD histogram at -0.0000 shows bearish momentum is flatlening, potentially signaling an imminent trend reversal.

Key moving averages paint a clear picture of the current downtrend, with AVAX trading well below its 7-day SMA ($8.80), 20-day SMA ($8.96), and significantly below longer-term averages. The 50-day SMA at $11.06 represents the first major technical target for any sustained recovery.

The Stochastic oscillator readings (%K at 5.84 and %D at 4.68) indicate severely oversold conditions, suggesting limited downside potential from current levels.

Avalanche Price Targets: Bull vs Bear Case Bullish Scenario The bull case for this AVAX price prediction hinges on a decisive break above the immediate resistance at $8.65, followed by a move through the critical $9.00 level. If Avalanche can reclaim the 20-day SMA at $8.96, it would signal the beginning of a potential recovery rally toward the $12-15 target range identified by multiple analysts.

Technical confirmation would come from RSI moving above 50 and MACD generating a bullish crossover. The 24-hour trading volume of $20.1 million provides adequate liquidity for such a move, though increased volume would strengthen the bullish case.

Bearish Scenario The bear case scenario sees AVAX failing to hold current support levels around $8.08. A breakdown below this level could trigger a move toward the strong support at $7.86. Any sustained trading below $7.86 would invalidate the near-term bullish outlook and potentially target lower levels around $7.00-7.50.

Risk factors include broader cryptocurrency market weakness and potential selling pressure from long-term holders looking to reduce positions after the significant decline from higher levels.

Should You Buy AVAX? Entry Strategy Based on current technical analysis, the most attractive entry point for this Avalanche forecast would be on any pullback toward the $8.08-8.20 support zone, with a stop-loss positioned below $7.80 to limit downside risk.

Aggressive traders might consider entering at current levels around $8.30, using the lower Bollinger Band as dynamic support. However, waiting for confirmation above $8.65 would provide greater confidence in the reversal thesis.

Position sizing should account for the high volatility, with the daily ATR of $0.43 suggesting significant intraday price swings. Risk management becomes crucial given the 4.16% decline in the past 24 hours.

Conclusion This AVAX price prediction suggests Avalanche is approaching a critical inflection point. While currently trading near technical support levels, the combination of oversold RSI conditions, analyst targets in the $12-15 range, and potential for momentum reversal creates a cautiously optimistic outlook for the next 4-6 weeks.

The path to the $12-15 target range represents potential gains of 44-80% from current levels, making Avalanche an intriguing consideration for traders willing to accept the inherent volatility risks. However, failure to hold support at $7.86 would significantly alter this forecast.

Disclaimer: Cryptocurrency price predictions are highly speculative and subject to extreme volatility. This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research and consider your risk tolerance before making investment decisions.

Image source: Shutterstock

avax price analysis avax price prediction
2026-02-24 12:11 2mo ago
2026-02-24 06:06 2mo ago
Bitcoin Falls Under $63K as Crypto Markets Shed $150 Billion cryptonews
BTC
📊
No votes yet – Be the first to vote

Bitcoin got hammered today. The world’s biggest cryptocurrency dropped below $63,000 for the first time since that nasty February 6 crash, and things aren’t looking pretty for the broader crypto space either.

The selloff didn’t happen overnight – Bitcoin’s been struggling since it got rejected above $70,000 last week. After that rejection, the digital asset basically went sideways, bouncing between $67,000 and $68,500 for several days before sliding to $65,600 on Thursday. Weekend trading brought some relief, but that didn’t last long. When legacy futures markets opened late Sunday, Bitcoin took another beating, plunging from $67,700 to $64,400 in just over an hour. A brief rally pushed it back to $66,500, but sellers stepped in again and drove the price below $63,000.

Bitcoin’s market cap now sits at roughly $1.260 trillion. Its dominance over other cryptocurrencies fell below 56%.

Ethereum’s having its own problems, dropping 5% to just above $1,800. The second-largest cryptocurrency can’t seem to catch a break as selling pressure mounts across the board. Other major altcoins like XRP, BNB, SOL, and TRX are all deep in the red too. Bitcoin Cash got hit particularly hard, tumbling over 11% to below $485. ZEC, RAIN, and UNI are also getting crushed in today’s selloff.

But there’s one bright spot in all the carnage.

PIPPIN bucked the trend completely, surging to a new all-time high of $0.80 with an 11.5% gain on the day. Sometimes the market just doesn’t make sense.

The broader cryptocurrency market lost more than $150 billion in value since Sunday, bringing the total market cap down to $2.260 trillion. That’s a massive chunk of wealth that just evaporated, and traders are pretty nervous about what comes next. The regulatory environment isn’t helping matters either. On February 21, the US Securities and Exchange Commission ramped up its scrutiny of digital assets, and that move probably contributed to the swift selloff we’re seeing across crypto markets.

Institutional players are feeling the heat too. Grayscale Investments, which runs the massive Bitcoin Trust, saw its assets under management drop by nearly $3 billion compared to the previous week as of February 23. That’s a clear reflection of how the broader market decline is hitting even the big institutional products. This follows earlier reporting on Bitcoin Drops Below ,500 as Altcoins.

Some investors are running for cover in stablecoins. Tether (USDT) and USD Coin (USDC) both saw trading volumes spike as traders moved their money into less volatile assets. Can’t really blame them – when Bitcoin’s swinging this wildly, stablecoins start looking pretty attractive.

Not everyone’s panicking though. JPMorgan put out a report on February 24 saying Bitcoin’s current price levels might actually attract new institutional buyers who see the dip as a good entry point. But the market’s still on edge, waiting for clearer signals about where things are headed next.

Coinbase reported a surge in withdrawal requests on February 23, with users moving serious amounts of digital assets off the platform. Bitcoin accounted for most of those withdrawals, which shows retail investors are getting nervous and moving their coins to private wallets. Meanwhile, Binance had a temporary outage on February 24 because of all the increased trading activity. CEO Changpeng Zhao jumped on Twitter to reassure users that they’re scaling their systems to handle the peak demand.

MicroStrategy’s still holding strong though. CEO Michael Saylor reaffirmed their commitment to Bitcoin during an investor call on February 22, saying the current market conditions won’t change their long-term strategy. The company views Bitcoin as a long-term asset, and they’re not budging from that position despite the recent volatility.

The Chicago Mercantile Exchange saw Bitcoin futures trading volumes jump over the past week. Open interest spiked significantly as of February 24, which means traders are still actively engaged despite the price drops. They’re probably trying to capitalize on all these short-term price swings. For more details, see XRP Markets See Institutional Buying as.

BlockFi announced stricter collateral requirements for borrowers on February 23 to protect against further downside risk. Kraken reported more margin calls among users as Bitcoin fell below critical support levels, leading to forced liquidations that added more downward pressure on prices.

The DeFi sector’s seeing some interesting activity though. Aave reported its total value locked increased 7% over the past week to $15 billion as of February 24, as investors look for alternative ways to generate yield during this market downturn.

The Bitcoin Mining Council released a statement on February 23 about the importance of transparency in mining operations. They think better communication about energy usage and mining practices could help calm investor concerns during stressful market periods like this one.

The Federal Reserve’s recent hawkish stance on interest rates has added another layer of pressure to risk assets like Bitcoin. Higher rates make traditional investments more attractive compared to speculative crypto holdings, and many analysts see this as a key driver behind the current selloff.

Several major crypto hedge funds have reportedly reduced their Bitcoin exposure over the past month. Three Arrows Capital and Alameda Research both cut their positions significantly, according to industry sources, while Galaxy Digital postponed its planned Bitcoin accumulation strategy until market conditions stabilize.

Post Views: 16
2026-02-24 12:11 2mo ago
2026-02-24 06:10 2mo ago
HBAR may retest $0.08665 as bearish sentiment dominates cryptonews
HBAR
Bitcoin (BTC), Ethereum (ETH), and Ripple (XRP) are all in the red as the cryptocurrency market continues its losing streak.

HBAR, the native coin of the Hedera ecosystem, also extended its losses and now trades below $0.10, down by nearly 4% since Monday.

Weakening on-chain and derivatives data support a bearish outlook alongside an unfavourable technical outlook.

On-chain and derivatives data support bearish biasHBAR has lost the $0.103 support level and is now trading at $0.09313, down by nearly 4% in the last 24 hours.

The bearish performance comes amid bearish derivatives data and negative sentiment in the market.

Santiment’s Social Dominance metric for Hedera currently shows a bearish bias.

The metric measures the share of HBAR-related discussions across the cryptocurrency media. 

This index has been on a decline since the end of December, falling again in February to 0.018% on Tuesday.

The decline indicates fading market interest and weakening sentiment among HBAR investors. 

The derivatives side also shows that retail traders are extremely bearish regarding HBAR’s price action.

CoinGlass data shows that HBAR’s futures Open Interest (OI) has declined to $90.18 million on Tuesday. 

The OI has been steadily declining since early January and is now approaching the February 6 level of $88.89 million.

This drop in OI reflects declining investor participation and projects a bearish outlook.

Hedera Price Forecast: Will HBAR retest the $0.08665 support level?Similar to the other leading cryptocurrencies, the HBAR/USD 4-hour chart is extremely bearish at the moment.

HBAR’s price was rejected around the 50-day Exponential Moving Average (EMA) at $0.103 ten days ago and has lost 10% of its value since then. 

Its 50-day EMA level roughly coincides with the upper trendline of a falling wedge pattern, making it a key resistance zone.

At press time, HBAR is trading at $0.093.

If the market correction persists, HBAR could extend the decline toward the weekly support at $0.090. 

Failure to defend this weekly support level will allow the bears to extend the losses toward the next daily support level at $0.072, which aligns with the October 10 low.

The market could encounter slight resistance at the February 6 low of $0.08665.

The Relative Strength Index (RSI) on the 4-hour chart is at 37, below the neutral level of 50 and approaching the oversold region, indicating bearish momentum gaining traction.

The Moving Average Convergence Divergence (MACD) lines are diverging, indicating bearish bias among traders.

If the MACD remains bearish, HBAR’s price could dip lower in the near term. 

On the other hand, if HBAR recovers, the coin could extend the advance toward the 50-day EMA at $0.103.

The recent swing high of $0.1079 could also serve as a target for the bulls.
2026-02-24 12:11 2mo ago
2026-02-24 06:12 2mo ago
Just-In: Ethereum Foundation Begins Staking 70,000 ETH, Futures Open Interest Bounces cryptonews
ETH
Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

The Ethereum Foundation on Tuesday said it has officially started in-house staking and plans to stake 70,000 ETH in the coming weeks as part of its treasury policy. This sparks massive buying in the derivatives markets as open interest bounces.

Ethereum Foundation Stakes 2016 ETH The Ethereum Foundation has begun staking a portion of its treasury, according to an official blog post on February 24. The foundation staked 2016 ETH worth $3.8 million as part of the plan to stake 70,000 ETH, generating rewards directed back to the EF treasury.

The foundation has selected Dirk and Attestant’s Vouch for staking ETH. Dirk acts as a distributed signer, enabling operation by individuals in multiple countries and ensuring no failure can interrupt validation. On the other hand, Vouch supports multiple Beacon Client and Execution Client pairings to mitigate client diversity risks.

The Ethereum Foundation reveals that the setup employs minority clients and a mix of hosted infrastructure and self-managed hardware in several jurisdictions. Notably, the treasury policy focuses on financial stability and operational efficiency, capping annual spending at 15% of total treasury assets and reducing it 5%.

“We are excited to take this important step, which helps secure the Ethereum network and at the same time fund the EF’s core operations & activities, including protocol R&D, ecosystem development, community grant funding and more,” the foundation said.

tl;dr: @ethereumfndn has started in-house staking and plans to stake ~70k ETH in the coming weeks. https://t.co/8RmZB3db67

— hww.eth | Hsiao-Wei Wang (@hwwonx) February 24, 2026

In this latest Voice of web3 podcast, Ethereum Foundation’s ecosystem head James Smith outlined how Ethereum is positioning itself as long-term, neutral global infrastructure rather than a short-term crypto adoption play.

Ethereum Futures Open Interest Rebound ETH price fell 5% in the past 24 hours amid the broader crypto market crash, currently trading at $1,820. The 24-hour low and high are $1,813 and $1,935, respectively. Trading volume has increased by almost 14% over the last 24 hours, indicating a rise in interest among traders.

Prices have dropped amid ETH selloffs by Vitalik Buterin and whales. Over the past 3 days, he has sold 3,788.57 worth $7.3 million. Notably, he has sold 10,723 ETH for $21.74 million this month.

ETH Selloffs by Vitalik Buterin. Source: Nansen However, Ethereum futures open interest jumped 0.40 in 4 hours and 0.22% in an hour to $23.43 billion after the Ethereum Foundation announced initial staking deposits. Coinglass data shows buying on exchanges such as Binance, OKX, KuCoin, and Coinbase. This signals positive sentiment among derivatives traders.
2026-02-24 12:11 2mo ago
2026-02-24 06:12 2mo ago
Satlantis Launches Bitcoin Lightning Ticketing Platform cryptonews
BTC
Satlantis has also amalgamated with Stripe to operate fiat payments and has said it plans to add stablecoin support. The Sacramento Kings was the first NBA team to accept Bitcoin for tickets and merchandise back in 2014.  Satlantis has rolled out an events and ticketing platform that implants Bitcoin Lightning Network wallets right into user accounts and individual events. This allows organisers to issue tickets and accumulate Bitcoin payments without tracking traditional payment processors. 

The platform works likewise to services such as Eventbrite and Luma, providing ticket tiers, attendee management, and event pages. Every event on the platform usually gets a unique Bitcoin wallet, permitting organisers to accept payments and extract funds directly in Bitcoin. 

Satlantis has also amalgamated with Stripe to operate fiat payments and has said it plans to add stablecoin support, providing organisers the capability to accept Bitcoin, traditional currency, or both via a single dashboard. 

The firm mentioned its model is made to suppress ticketing fees and widen payment access in areas where conventional payment infrastructure is finite. The Lightning Network permits reduced-cost quick transactions by processing payments off-chain instead of settling every transaction directly on the Bitcoin base layer. 

The Craze of Crypto into Event Ticketing  As per the data quoted by River marketing director Sam Wouters, the network listed around $1.1 billion in transaction volume over 5.2 million transactions in November. As per the firm’s crowdfunding page, investors in Satlantis comprise Bitcoin Opportunity Fund and Timechain Capital, a venture capital fund aimed at Bitcoin infrastructure projects. 

The history of bringing crypto into event ticketing traces long back. The Sacramento Kings was the first NBA team to accept Bitcoin for tickets and merchandise back in 2014, and the Dallas Mavericks followed in 2019. 

Talking about blockchain settlement, TIX, the on-chain network behind KYD Labs, is working to tokenise tickets as real-world assets that can be used to access capital and automate repayment. 

FIFA has also set its foot into the space before the 2026 World Cup, selling “right-to-buy” NFT tokens that grant holders a reserved window to buy match tickets at face value if some given conditions are met. 

Highlighted Crypto News Today: 

WLFI Stablecoin USD1 has Recovered from Coordinated Attack

A passionate journalist with a strong foundation in content writing and an experience in the crypto industry. With a commitment to self-growth, Sharmistha aims to make a meaningful impact in the media and communications landscape.
2026-02-24 12:11 2mo ago
2026-02-24 06:14 2mo ago
ASTER holds range as traders position for March mainnet launch cryptonews
ASTER
ASTER traded flat into mid-February as traders priced in March mainnet launch.

Summary

ASTER consolidated in an accumulation zone into Feb. 19, with traders watching a key resistance level that could open upside targets if broken amid broader market weakness.​ Token Terminal showed 6 daily, 44 weekly and 340 monthly active addresses as of Feb. 18, highlighting thin underlying usage versus the bullish technical and positioning setup.​ A fee-to-buyback model directs up to 80% of platform fees to on-chain buybacks, while a Stage 6 airdrop distributing 64m ASTER (0.8% supply) runs through Mar. 29 alongside a March mainnet window.​ ASTER token consolidated through mid-February as market participants positioned ahead of the project’s scheduled March mainnet launch, according to trader analysis and project roadmap data.

Trader Don Wedge identified an accumulation zone in a chart posted February 19, highlighting a key resistance level that, if breached, could enable movement toward higher price targets, according to the posted analysis.

The token’s price movement occurred during a broader cryptocurrency market decline, suggesting positioning centered on project-specific developments rather than general market sentiment shifts, according to market observers.

Trader Shuarix stated February 19 that momentum was building ahead of the March mainnet window, citing confirmed mainnet timing, increased on-chain activity, and pre-launch positioning as factors driving price action.

Aster Chain‘s official roadmap lists the Layer 1 mainnet launch in the first quarter of 2026, with multiple reports indicating March as the target delivery period. Mainnet launches typically establish token utility through transaction fees, staking mechanisms, and governance functions.

Token Terminal data as of February 18 showed six daily active addresses, 44 weekly active addresses, and 340 monthly active addresses on the network. The usage figures raised questions about whether fundamental network adoption supported the technical price setup.

A whale position on Hyperliquid held a four-times leveraged long position open for 22 days as of February 19, according to on-chain data. Large leveraged position exits can trigger selling pressure and cascading liquidations, according to market analysts.

Aster implemented a fee-to-buyback mechanism starting February 4, directing up to 80 percent of daily platform fees toward on-chain token buybacks, according to project documentation. Approximately 40 percent functions as automatic daily buybacks, with 20 to 40 percent allocated to a strategic wallet for discretionary purchases.

The buyback structure creates proportional bid support tied to platform volumes and fees, according to the mechanism’s design. If activity increases ahead of mainnet, buyback flows rise correspondingly; reduced activity diminishes the bid structure.

Aster’s Stage 6 airdrop phase, designated “Convergence,” runs from February 2 through March 29, 2026, allocating approximately 64 million ASTER tokens, representing 0.8 percent of total supply, according to project announcements. The distribution marks the final transaction-activity-based phase before emissions transition to staking-based rewards.

Airdrop completion could reduce selling pressure from participants accumulating points, potentially affecting price volatility post-claim, according to market analysts.

The project roadmap lists fiat on-ramp and off-ramp integration via third-party providers for the first quarter of 2026. Staking and governance features are scheduled for the second quarter of 2026, according to the published timeline.

The mainnet launch window, fee buyback mechanism, and airdrop phase conclusion provide structural developments supporting technical price action, according to market analysis. Token Terminal’s usage metrics indicate fundamental gaps that mainnet delivery may not resolve without sustained adoption growth, according to the data.

Market participants positioned for resistance breakouts face execution risk if large leveraged holders exit before key price levels clear, according to trading analysts monitoring the setup.
2026-02-24 12:11 2mo ago
2026-02-24 06:17 2mo ago
Bitcoin eyes $60k as Kraken VP warns of deeper tariff-led slide cryptonews
BTC
BTC fell about 5% in days as tariffs and geopolitics drove downside risk.

Summary

BTC is in a sharp correction similar to equities, with renewed tariff uncertainty and geopolitical tensions cited as primary downside catalysts in the short term.​ Kraken VP Matt Howells-Barby flags ~$60k as critical support and warns a breakdown could open a path toward the mid-to-low $50k range.​ Historically, BTC has not bottomed until the 50-week MA drops below the 100-week MA in a death cross, implying potential further downside before a durable floor forms. Matt Howells-Barby, Vice President of cryptocurrency exchange Kraken, identified critical price levels for Bitcoin as the digital asset undergoes a correction, according to statements from the executive.

Howells-Barby stated that Bitcoin is experiencing a sharp correction similar to movements in equity markets, with uncertainty surrounding tariffs cited as one of the primary factors driving the decline. The executive drew comparisons to macroeconomic pressure observed in April of the previous year, noting that geopolitical tensions could present additional downside risks in the short term.

The Kraken executive pointed to a critical support level as a technically significant threshold. According to Howells-Barby, a break below this support could push Bitcoin prices down to the lower-to-mid range.

Howells-Barby referenced historical data indicating that Bitcoin typically does not establish a clear bottom until the 50-week moving average falls below the 100-week moving average, a technical pattern known as a “death cross.” The absence of such a cross suggests the possibility of further declines extending below the lower range, according to the analysis.

Market analysts indicate that volatility may remain elevated in the current environment, with investors advised to focus on risk management strategies.
2026-02-24 12:11 2mo ago
2026-02-24 06:20 2mo ago
Dogecoin Shows Early Signs of Momentum Shift Against Bitcoin cryptonews
BTC DOGE
Dogecoin shows early signs of outperformance against Bitcoin as weekly RSI ticks higher, signaling potential breakout in DOGE/BTC pair.

Newton Gitonga2 min read

24 February 2026, 11:20 AM

Edited 24 February 2026, 11:21 AM

Dogecoin may be positioning for a potential price breakout against Bitcoin, according to crypto trader Surf. He shared a weekly chart update highlighting subtle gains in both price and the Relative Strength Index (RSI). 

Bitcoin price has dipped 4.85% over the past day, trading at $63,219, while Dogecoin posted a modest 5.61% loss. The divergence from Bitcoin is fueling speculation that DOGE could outperform the leading cryptocurrency if momentum continues.

Weekly Chart Signals Growing ConfidenceSurf posted a follow-up tweet reading “Good DOGE,” signaling optimism after earlier analysis of the DOGE/BTC weekly chart. The chart shows Dogecoin in a long-term downtrend against Bitcoin, yet the RSI has pushed slightly higher. 

Technical analysis suggests that a rising RSI amid price compression can indicate weakening selling pressure. According to Surf, the subtle uptick in both price and RSI strengthens the setup, making it noteworthy for traders observing weekly closes.

The weekly close is particularly significant as it reflects sustained buying or selling pressure over multiple days, offering a clearer picture than intraday movements. Surf emphasized he was “watching the close,” indicating that confirmation of trend change would come only if momentum held through the weekly candle. Traders interpret the RSI pressing against a descending resistance line as an early signal that Dogecoin may be ready for a larger move.

Implications for Dogecoin and BitcoinAt press time, Dogecoin price is trading at $0.09091, erasing earlier losses and entering positive territory. If the current trend endures, Dogecoin could begin outperforming Bitcoin, attracting capital rotation toward meme coins. Analysts caution that Bitcoin’s stability is crucial, a deeper dip in Bitcoin could quickly reduce DOGE gains as investors withdraw from higher-risk assets.

Surf’s chart update highlights that momentum shifts often start subtly, with early RSI movements preceding price action on higher timeframes. Traders watching the DOGE/BTC pair now see the slight RSI push as a potential prelude to a trend reversal. If Dogecoin sustains its weekly gains and RSI breaks above resistance, the downtrend against Bitcoin could weaken, opening opportunities for further upward movement.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Newton Gitonga covers cryptocurrencies, blockchain, and digital finance. He specializes in breaking down complex trends with clear, data-driven reporting. His work focuses on market analysis, technical insights, and the evolving role of altcoins in shaping global markets.

Read more about

BitcoinDogecoin (DOGE) News
2026-02-24 12:11 2mo ago
2026-02-24 06:30 2mo ago
Dogecoin Warning: Analyst Says DOGE May Fall To $0.06 cryptonews
DOGE
Dogecoin is facing another bearish technical call after trader Cheds Trading (@BigCheds) posted a weekly DOGE/USD chart via X on Feb. 24 and said the memecoin “looks headed for 6 cents .06 range.” The setup matters because the chart he shared shows DOGE already trading below a stack of key weekly trend indicators, with the next widely visible support region lower.

Is Dogecoin Heading To $0.06? Cheds’ comment was brief and direct: “DOGE looks headed for 6 cents .06 range”. The TradingView chart is a 1-week DOGE/USD Coinbase chart. The chart’s indicator panel shows DOGE trading below all the visible moving averages cited on the screenshot.

Dogecoin price analysis, weekly chart | Source: X @BigCheds The EMA 8 is marked at $0.10823, the SMA 200 at $0.13578, the EMA 34 at $0.15734, and the SMA 50 at $0.17912. With price at $0.09135, DOGE is beneath each of those levels, which supports the analyst’s argument that the weekly structure remains weak unless price can reclaim them.

The Bollinger Bands shown on the same chart also provide context. The screenshot lists BB 20 (2) values at $0.13861 (basis), $0.20395 (upper band), and $0.07328 (lower band). That places DOGE closer to the lower band than the midline and well below the basis, consistent with downside pressure on the weekly timeframe.

Cheds’ $0.06 target would also imply a move below the currently displayed lower Bollinger Band level of $0.07328, which frames the call as a deeper continuation scenario rather than a simple drift within the current volatility envelope. From the displayed close of $0.09135, a move to $0.06 would represent roughly another 34% downside.

The chart shows continued low trading volume, with price continuing to slide after failing to hold higher levels visible earlier in the cycle. In practical terms, the chart Cheds shared supports a straightforward thesis: DOGE is below near-term and medium-term trend references, and the burden of proof remains on buyers.

Unless DOGE can reclaim some of those weekly indicator levels, starting with the EMA 8 at 0.10823, the analyst’s call for a retest toward the $0.06 area remains aligned with the chart structure shown. Notably, DOGE has fallen below the October 10 crash low at $0.095. The next support could be near $0.08, a price DOGE visited already three weeks ago. The price also marked the August 2024 bottom.

At press time, DOGE traded at $0.09142.

DOGE falls below the October 10 low , 1-week chart | Source: DOGEUSDT on TradingView.com Featured image created with DALL.E, chart from TradingView.com
2026-02-24 12:11 2mo ago
2026-02-24 06:32 2mo ago
Arizona advances bill to hold Bitcoin and XRP in state reserve cryptonews
BTC XRP
Lawmakers in Arizona have taken a significant step toward formalizing state-level engagement with digital assets by advancing legislation that would create a Digital Assets Strategic Reserve Fund, allowing the state to hold, invest and potentially lend seized cryptocurrencies.

Summary

Arizona lawmakers advanced Senate Bill 1649, which would create a Digital Assets Strategic Reserve Fund allowing the state to hold, invest and potentially lend seized cryptocurrencies. The fund would be administered by the State Treasurer and capitalized using confiscated or forfeited crypto assets rather than taxpayer funds. Eligible assets include Bitcoin, XRP and DigiByte, marking a notable step toward formal state-level recognition of digital assets. Arizona senate backs crypto reserve fund The measure, Senate Bill 1649 (SB1649), cleared the Senate Finance Committee in a 4–2 vote and was subsequently approved by the Senate Rules Committee, moving it closer to a full Senate vote.

Under the proposed law, the Arizona State Treasurer would administer the reserve, using assets that have been confiscated, forfeited or surrendered through criminal or civil enforcement actions. Instead of relying on taxpayer dollars to acquire crypto on the open market, the fund would be capitalized with these seized holdings.

Eligible assets named in the bill include Bitcoin (BTC), XRP (XRP) and DigiByte, alongside other digital assets that meet specified “fair value” criteria such as stablecoins and non-fungible tokens.

The inclusion of XRP in the reserve’s eligibility framework marks a notable development for the token, as it would represent one of the first instances of a U.S. government entity formally recognizing it as a potential reserve asset.

While the legislation does not require the state to immediately purchase or hold these assets, it establishes a legal structure for doing so in the future.

The bill’s progress highlights a broader trend in U.S. crypto policy, with several states exploring ways to integrate digital assets into public finance strategies.

However, similar initiatives in Arizona have faced pushback in the past from Governor Katie Hobbs, who has expressed caution about exposing state funds to cryptocurrency volatility. SB1649 must still pass both chambers of the legislature and survive executive review before becoming law.
2026-02-24 12:11 2mo ago
2026-02-24 06:33 2mo ago
WLFI Price In Trouble as Whale Activity Spikes: Is More Downside Ahead? cryptonews
WLFI
WLFI price is flashing clear signs of weakness as sellers tighten their grip. The token has declined for three straight sessions, repeatedly failing to break above the 20-day EMA, while recent whale transfers to exchanges have added fresh selling pressure. The combination of price rejection and large on-chain movements is keeping sentiment cautious. With WLFI price struggling to regain momentum and distribution signals emerging, the key question now is: What’s next for WLFI price, a deeper correction or a surprise rebound?

Whale Activity Raises Fresh Concerns: More Distribution Ahead?Recent on-chain data has amplified bearish concerns. According to Lookonchain, wallet address 0x5041 received 26.6 million WLFI tokens, valued at approximately $3.2 million, from a World Liberty Financial-linked wallet. Shortly after, 6 million WLFI tokens, worth around $664,000, were transferred to Binance.

Large deposits to exchanges are closely watched because they often signal preparation for selling. While not every transfer leads to immediate liquidation, such activity typically increases short-term downside risk. The timing of this deposit aligns closely with WLFI’s recent price drop, reinforcing the distribution narrative. When whale movement and technical weakness appear together, markets tend to stay defensive.

WLFI Price Structure Shows Continued Downtrend: Is $0.10 Breakdown Next?WLFI remains locked in a clear short-term downtrend. The token is currently trading around the $0.107–$0.110 range after multiple failed attempts to reclaim resistance near the 20-day EMA, positioned between $0.115 and $0.118.

Each rejection at this moving average confirms that sellers remain in control. Instead of forming higher highs, WLFI continues to print lower highs, which keeps the bearish structure intact. Immediate support now sits near $0.10. If this level breaks, price could slide toward the $0.095 region, where previous demand emerged. A deeper correction may extend toward $0.090 if broader market weakness persists. On the upside, WLFI must close decisively above $0.118 to shift short-term momentum back to neutral. Without that reclaim, rallies are likely to remain corrective rather than trend-changing.

The Relative Strength Index (RSI) is trading below the neutral 50 level, signaling that buyers lack strong control. At the same time, WLFI is not yet deeply oversold, meaning additional downside remains possible before a meaningful relief bounce develops.

Outlook: Can WLFI Price Stabilize?WLFI remains under pressure as technical rejection and whale exchange deposits weigh on sentiment. If price fails to hold above $0.10, further downside toward $0.095 or even $0.090 could follow. For any recovery to gain credibility, WLFI must reclaim and sustain levels above $0.118, turning resistance back into support. Until that shift occurs, the trend remains tilted toward the downside, and traders are likely to stay cautious.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2026-02-24 12:11 2mo ago
2026-02-24 06:37 2mo ago
Crypto markets bleed as bitcoin hovers above liquidation zone cryptonews
BTC
Crypto markets bleed as bitcoin hovers above liquidation zoneBitcoin dropped to $63,000 as the dollar climbed and equities weakened. A break below $60,000 risks further liquidations and a slide toward $52,500. Feb 24, 2026, 11:37 a.m.

Bitcoin investors are running to the exits. (Markus Pfaff/Shutterstock modified by CoinDesk)

What to know: BTC is down 4.7% in 24 hours to $63,100; a break below $60,000 could open the door to liquidations and a move toward $52,500 support.BCH dropped 11.5%, while APT, ATOM and SUI fell 5%–8% as liquidity thins and sell pressure intensifies.DeFi TVL is holding up better than token prices, suggesting rotation into stablecoins, while RSI signals hint at a potential short-term bounce.Bitcoin BTC$63,213.15 fell for a fourth straight day to around $63,100, its lowest since Feb. 6's $60,200, CoinDesk data show.

The latest move to the downside coincides with risk-off sentiment from investors across global markets. U.S. equities have lost ground this week, and the dollar index (DXY) rose by 0.5% since Asian hours on Monday.

STORY CONTINUES BELOW

BTC is down by 2.1% since midnight UTC and 4.7% over the past 24 hours. A break below $60,000 would trigger another round of liquidations and a possible leg down to as low as $52,500, which is a historical level of support dating back to 2021.

The altcoin market also appears battered and bruised on Tuesday. BCH$479.28 lost 11.5% of its value over the past 24 hours with a 3% drawdown since midnight UTC, while SUI, JUP, PUMP and WLFI all lost more than 2%.

Analysts are describing price action as a "slow bleed" typical of previous cryptocurrency bear markets, although it's worth noting that the average crypto relative strength index (RSI) indicator is flashing an "oversold" signal, meaning there is potential for a bounce in the low $60,000 region.

Derivatives positioningNotional open interest in the crypto futures market dropped more than 4% to $92.5 billion, the lowest since early April 2025. The relentless slide shows continued de-risking by investors, who are moving capital out of leveraged products.Exchanges have liquidated $360 million worth of leveraged bets in 24 hours. Bullish bets or longs faced the brunt, accounting for over 90% of total liquidations on several exchanges, including Hyperliquid, HTX, Aster, Bitmex and Bitfinex. Some traders look to be shorting bitcoin in a weak market. That's evident from the increase in global open interest in bitcoin futures to 690.89K BTC, the highest since Feb. 6. The same is true for ether. Annualized funding rates in perpetuals tied to major tokens remain below zero, indicating a bias for bearish, short positions. TRX and TRON have funding rates as low as -35%, a sign of the market slowly becoming overcrowded with shorts. Bitcoin and ether's 30-day implied volatility indices have risen to two-week highs, indicating renewed market jitters. On Deribit, bitcoin and ether put options are trading at over 10 volatility premium to calls out to end-March expiry. This shows heightened concerns of an extended price selloff. Block flows featured BTC put spreads and straddles. A put spread is a bearish strategy with a limited-profit, limited-loss profile. Straddles represent a bet on volatility. Token talkWith the exception of pippin (PIPPIN), an AI-related token that has doubled since the turn of the year after rising by 7.7% in the past 24 hours, the altcoin market is suffering from a lack of bullish catalysts.The decentralized finance (DeFi) market has lost less total value locked (TVL) than the value of assets has depreciated, suggesting traders and investors are moving to stablecoins to mitigate risk.This has led to poor performance among DeFi tokens, with CoinDesk's DeFi Select Index (DFX) losing 34.8% since the turn of the year to make it the worst-performing benchmark.Layer-1 tokens aptos APT$0.8120, ATOM$2.0326 and SUI$0.8572 all fell 5% to 8% over the past 24 hours as the altcoin market grapples with a lack of liquidity and relentless waves of sell pressure.More For You

Canaan buys Cipher’s 49% of West Texas mining venture for $39.75 million in stock

1 hour ago

The transaction gives Cipher a major shareholding in the Singapore-based company.

What to know:

Canaan Inc. acquired Cipher Mining’s 49% equity interest in the ABC Projects, three operational bitcoin mining sites in West Texas.The $39.75 million transaction was funded through the issuance of 806.4 million Class A ordinary shares.Top Stories
2026-02-24 12:11 2mo ago
2026-02-24 06:41 2mo ago
XRP bucks trend with $3.5m inflows as crypto funds bleed cryptonews
XRP
XRP products gained ~$3.5m last week while crypto funds lost ~$288m.

Summary

Crypto investment products saw ~$288m in weekly outflows, extending a five-week streak that has pulled about $4b from digital asset funds amid the lowest trading volumes since mid‑2025. BTC products lost ~$215m last week, taking YTD outflows to ~$1.3b, while ETH, TRX and multi‑asset products saw ~$36.5m, ~$18.9m and ~$32.5m exit respectively; short‑BTC vehicles drew ~$5.5m in fresh capital. XRP drew ~$3.5m of inflows on the week and ~$33.4m the week before, lifting month‑to‑date and YTD inflows to about $105m and $151m; SOL added ~$3.3m and LINK ~$1.2m over the same period. XRP (XRP)-linked investment products attracted approximately $3.5 million in net capital inflows last week, even as broader cryptocurrency products experienced outflows totaling $288 million, according to the latest CoinShares weekly flow report.

The data marks the fifth consecutive week of net withdrawals from crypto investment vehicles, pushing cumulative outflows to approximately $4 billion over this period, the report stated. Trading volumes have declined to their lowest levels since July 2025.

The United States represented the largest source of global outflows, with investors withdrawing $347 million in a single week, according to the report. In contrast, Switzerland recorded $19.5 million in inflows, Canada added $16.8 million, and Germany attracted $16.2 million, totaling approximately $59 million in combined inflows.

Bitcoin-linked investment products recorded $215 million in outflows during the week, pushing year-to-date withdrawals to around $1.3 billion, the data showed. Ethereum-related products experienced $36.5 million in weekly outflows, while Tron-related products recorded $18.9 million in outflows and multi-asset products saw $32.5 million exit. Short-Bitcoin products attracted $5.5 million in inflows, according to CoinShares.

XRP remained among the few cryptocurrencies to attract new capital during the market pullback, drawing $3.5 million in fresh inflows last week and $33.4 million the week prior, the report stated. The token’s month-to-date inflows reached $105 million, with year-to-date inflows totaling $151 million.

Solana-linked products recorded inflows of $3.3 million last week, bringing its month-to-date total to approximately $41.6 million and its year-to-date figure to about $102.5 million, according to the data. Chainlink products attracted $1.2 million in inflows.

The divergence in flows suggests investors are reallocating capital within the cryptocurrency sector rather than exiting entirely, according to market analysts. XRP trades at a lower price point than Bitcoin, potentially lowering barriers to entry for some investors. The token has also benefited from regulatory clarity following legal proceedings, analysts noted.

Total crypto trading volume fell to its lowest level since mid-2025, reflecting reduced market participation, the CoinShares report indicated.
2026-02-24 12:11 2mo ago
2026-02-24 06:43 2mo ago
XRP active addresses crash to the lowest level in 2026 cryptonews
XRP
On-chain metrics for XRP are painting a troubling picture, showing that the number of unique active addresses on the XRP Ledger (XRPL) have fallen to their lowest level in 2026.

Specifically, as of February 24, the number of XRP Ledger active addresses sits at 14,551, down from the 2026 peak of 32,684 seen on February 10, as per data retrieved by Finbold from on-chain market data analytics platform CryptoQuant.

XRP Ledger active addresses. Source: CryptoQuant XRP Ledger activity drops XRP active addresses are widely viewed as a key measure of blockchain health, reflecting overall user engagement, meaning the 55% decline in activity signals weakening activity across the Ledger.

However, the decline in publicly visible XRPL activity metrics may reflect institutional trading migrating into private permissioned pools rather than a sharp drop in overall demand.

Ripple also plans on introducing native lending functionality and zero-knowledge, proof–based privacy tools under a future XRPL 3.0 framework. These updates could expand on-chain credit markets and deepen institutional participation, reversing the negative trend.

Nonetheless, it must be mentioned that the shift toward gated liquidity comes with some fresh concerns. For example, liquidity fragmentation between open and permissioned order books could affect price discovery. 

At the same time, traditional retail-facing metrics may no longer fully capture on-chain activity, as a greater share of volume could occur within credential-gated environments rather than fully open markets.

All in all, then, the longer-term development remains constructive. Ripple has XRPL upgrades slated for 2026 aimed at enhancing tokenization and institutional functionality. Additionally, Japan’s SBI Holdings is issuing blockchain-based bonds with XRP-linked rewards, suggesting institutional experimentation with the asset is far from over.

What’s next for XRP? Meanwhile, XRP has lost nearly 30% year-to-date, currently trading around $1.33 and threatening to drop below $1 in the following days, as whale activity goes up.

YTD XRP price. Source: Finbold New data shows that more than 31 million XRP tokens were transferred to Binance in a single day. The surge in exchange inflows was driven almost entirely by whale wallets.

In the days leading up to the surge, exchange inflows remained relatively muted, and sharp increases in whale inflows to exchanges have historically preceded heightened volatility, as such transfers often signal intent to sell. 

If a meaningful portion of the 31 million-plus XRP is liquidated, it could intensify selling pressure and raise the risk of a move below the key $1 support level.

Featured image via Shutterstock
2026-02-24 12:11 2mo ago
2026-02-24 06:47 2mo ago
Bitcoin death cross is imminent in 3 days, warns analyst cryptonews
BTC
Technical indicators are signaling the risk of a sustained Bitcoin (BTC) drop in the coming days as the asset struggles to hold the $60,000 support level.

In this context, Bitcoin is on the verge of printing a major bearish signal on the three-day chart, with a death cross between the 50-day and 200-day simple moving averages (SMA) projected to occur around February 27, according to insights from Ali Martinez.

In an X post on February 24, the analyst noted that the setup follows a prolonged decline that began with Bitcoin’s peak in October 2025. 

Since then, the cryptocurrency has dropped more than 52%, falling from above $110,000 to around $68,000. The sell-off has intensified recently, with the price breaking below both the 50 and 200 SMAs as downside momentum strengthens.

On the three-day chart, the 50 SMA is sloping downward and nearing the 200 SMA, signaling that bearish momentum has overtaken the broader trend. If confirmed in the coming days, it would mark the first death cross of this cycle on the higher timeframe.

Bitcoin price analysis chart. Source: Ali Martinez Historical impact of death cross on BTC  Historically, similar setups have preceded the final capitulation phase of bear markets. In 2013, Bitcoin had already fallen over 70% before the cross, followed by another roughly 50% decline. 

A similar pattern unfolded after the 2017 peak and again in 2021, when the death cross appeared after a steep sell-off and preceded the final leg down into the macro bottom.

Bitcoin price analysis chart. Source: Ali Martinez According to Martinez, Bitcoin’s structure mirrors prior cycles, with the asset already down more than 50% from its October 2025 peak. 

Now, the looming death cross suggests selling pressure may persist. Historically, comparable setups have preceded the final leg lower, implying a potential 30% drop toward $40,000 or, in a deeper move, 50% toward $30,000. 

While not a guarantee, past cycles show the death cross often aligns with the last major downswing before a macro bottom forms.

Bitcoin drops further below $65,000 Meanwhile, Bitcoin extended losses Tuesday, slipping further below $65,000. By press time, BTC was trading at $63,158, down nearly 5% in the past 24 hours, while on the weekly timeframe, the asset has fallen more than 6%.

Bitcoin seven-day price chart. Source: Finbold  The decline is largely tied to renewed U.S. trade policy uncertainty under President Donald Trump. After a Supreme Court ruling curtailed earlier tariff powers, Trump introduced and later raised a new global import tariff to 15%, stoking fears of trade disruption, slower growth, and higher inflation. 

The move triggered broad risk-off sentiment, pushing investors out of volatile assets like cryptocurrencies and into traditional safe havens such as gold. 

Analysts view the sell-off as tactical de-risking rather than outright capitulation, driven by leverage unwinds, sustained ETF outflows, and cascading liquidations.

Featured image via Shutterstock